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ABSTRACT 
Elizabeth J. Sacho: Biophysical and Biochemical Investigations of Proteins Involved in 
Genomic Stability 
(Under the direction of Dr. Dorothy A. Erie) 
 
 
  
 The processes by which cells either make or avoid mutations in their DNA are 
varied and multifaceted.  Often proteins involved in the repair of DNA damage are also 
found inducing mutations in the immune response.  Despite the fact that these proteins 
and processes are found in all eukaryotes, the scientific community is just beginning to 
elucidate the mechanisms of these diverse pathways and the functions of the proteins 
involved in them.  This dissertation looks at proteins in two seemingly different cellular 
processes:  DNA mismatch repair and the immune response, as modulated by cytidine 
deaminases.   
The DNA mismatch repair protein MutLα has been long thought to function as a 
molecular matchmaker; facilitating interactions between proteins in the mismatch repair 
pathway.  Since little was known about this protein, biophysical and biochemical assays 
were designed and carried out to elucidate what role binding of ATP and DNA may have 
on MutLα. Surprisingly, MutLα can exist in four different conformational states, and
these conformational states are governed by adenine nucleotide binding (but not 
hydrolysis).   
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It had been shown previously that MutLα binds to DNA in long, cooperative 
protein tracts.  MutLα protein tracts do not appear to be effected by increasing salt 
concentration, but they are affected by the presence of ATP.  Additionally, the ATP 
hydrolysis rate of full-length MutLα was measured, and found to be 2-6x larger than 
values previously reported for isolated N-terminal domains of MutLα, suggesting that 
conformational changes seen upon ATP binding, and the interactions that are likely made 
as a result of those conformational changes, may enhance the rate of ATP hydrolysis by 
MutLα. 
Two of the cytidine deaminases (AID and APOBEC3G) have been shown to be 
involved in the immune response.  The third cytidine deaminase (APOBEC2) is only a 
cytidine deaminase by sequence homology; and as yet has unknown function.  Since it is 
widely believed that all cytidine deaminases are dimeric or tetrameric, a study of the 
oligomeric states of these proteins (with and without substrate present) was undertaken.  
Despite all three proteins belonging to the same superfamily, they each appear to exist in 
a different oligomeric state. 
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 CHAPTER 1 
INTRODUCTION 
 
The stability of an organism’s genome is challenged every day by both internal 
and external forces. Consequently, a multitude of processes have evolved to deal with the 
inevitable genomic insults.  Some of these genomic changes, for example the introduction 
of the wrong nucleotide into a growing DNA strand, can be deleterious to the organism.  
Other changes, such as the mutations of DNA in the process of adaptive immunity, are 
advantageous to the organism.  
Mutations in genomic DNA, depending on the frame of reference, can be either a 
good or bad thing.  A good thing, in the case of voluntary mutations caused by proteins in 
the process of passive and adaptive immunity, and a bad thing, in the case of involuntary 
mutations caused by internal and external sources.  This dissertation focuses on 
characterizing the biophysical and biochemical properties of proteins involved in both the 
repair of mutations via the DNA mismatch repair system and the induction of mutations 
(for the purpose of adaptive immunity) by the cytidine deaminases that make up the 
AID/APOBEC family.  
DNA Mismatch Repair  
DNA mismatch repair (MMR) is one of several DNA repair processes that are 
vital for maintaining genome stability.  In DNA synthesis, a mismatch (non-Watson-
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Crick base pairing) occurs once in every 106-107 base pairs.  The MMR system has been 
shown to post-replicatively improve the fidelity of DNA synthesis by 100-1000 fold 
(Bellacosa 2001).  The MMR machinery is able to correct not only mismatches but also 
insertion-deletion loops (IDLs), which may occur during replication and recombination 
of DNA.  
Mutations or deficiencies in the MMR system have been linked to an increased 
incidence of DNA mutations which can lead to cancer (Bellacosa 2001).  Specifically, 
mutations in the DNA MMR proteins have been linked to hereditary non-polyposis 
colorectal cancer (HNPCC) (Liu, Yan et al. 2001; Hoffmann, Shcherbakova et al. 2003; 
Li 2003).  HNPCC is characterized by an early onset of colorectal cancer as well as an 
increased frequency of other cancers, including cancers of the endometrium, stomach, 
ovary, pancreas, and urinary tract (Liu, Yan et al. 2001).  
Mismatch Repair in E. coli 
The process of MMR is best understood in Escherichia coli (E. coli), where it is 
carried out by the mismatch repair proteins MutS, MutL and MutH alongside the cellular  
replication machinery (Modrich and Lahue 1996). DNA repair via the MMR pathway 
(see Fig. 1.1) is initiated when MutS binds to the mismatch.  MutL then binds to the 
MutS-mismatch complex in an ATP-dependant manner.  Next, the MutS-MutL-mismatch 
complex activates a MutH bound at a hemi-methylated GATC site.   The hemi-
methylation of the DNA serves as the discrimination signal between the parent 
(methylated) and daughter (un-methylated) strand.  MutH, a latent endonuclease, then 
cuts the daughter strand, making a nick that is accessible to a DNA helicases (UvrD) and 
an exonuclease.  The excision of the mismatch starts at the nick and continues ~100 base 
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pairs past the mismatch.  The replicative E. coli DNA polymerase (Pol III) then 
resynthesizes the DNA, and DNA ligase seals the nick (Au, Welsh et al. 1992; Modrich 
and Lahue 1996; Kunkel and Erie 2005; Iyer, Pluciennik et al. 2006).   
The first two proteins involved in MMR in E. coli, MutS and MutL, are conserved 
in higher eukaryotes.  In E.coli and other prokaryotes, MutS and MutL function as 
homodimers.  However, in eukaryotes, the MutL and MutS homodimers are replaced by 
an array of heterodimers.  A comparison between E. coli, S. cerevisiae, and human MutS 
and MutL proteins is found in Table 1.1.   
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Figure 1.1 
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Figure 1.1:  Schematic of E. coli MMR.  
MMR can occur from both 5’ to the mismatch (repair pathway on the left) or 3’ to the 
mismatch (repair pathway on the right).  DNA repair is initiated by the binding of MutS 
to the mismatch.  MutL then binds to the MutS-mismatch complex in an ATP-dependant 
manner.  Next, the MutS-MutL-mismatch complex activates a MutH bound at a hemi-
methylated GATC site. MutH, a latent endonuclease, then cuts the daughter strand, 
making a nick that is accessible to a DNA helicase (UvrD) and an exonuclease.  The 
excision of the mismatch starts at the nick, and continues ~100 base pairs past the 
mismatch.  The replicative E. coli DNA polymerase (Pol III) then resynthesizes the DNA, 
and DNA ligase seals the nick 
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E. Coli S. cerevisiae Human 
MutS yMsh1 ? 
" yMutSα (yMsh2-Msh6) hMutSα (hMsh2-Msh6) 
" yMutSβ (yMsh2-Msh3) hMutSβ (hMsh2-Msh3) 
" yMsh4 hMsh4 
" yMsh5 hMsh5 
MutL yMutLα (yMlh1-Pms1) hMutlα (hMlh1-Pms2) 
" yMutLβ (yMlh1-Mlh2) hMlhβ (hMlh1-Pms1) 
" yMlh3 hMlh3 
 
Table 1.1: Comparison between E. coli, S. cerevisiae and Human MMR proteins 
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Eukaryotic Mismatch Repair 
While the E. coli MMR system is well understood, it is becoming apparent that it 
may not be representative of MMR in eukaryotes.  For example, there are more proteins 
involved in DNA replication in eukaryotes, there is no MutH homolog in eukaryotes, and 
the strand discrimination signal is unknown. Additionally, in eukaryotes the proteins 
MutS and MutL exist as the heterodimeric proteins MutSα and MutLα (Table 1.1).  
MutSα has been shown to be asymmetric in its binding to ATP as well as its interactions 
with DNA mismatches (Dufner, Marra et al. 2000; Drotschmann, Hall et al. 2002; 
Drotschmann, Yang et al. 2002; Warren, Pohlhaus et al. 2007), and MutLα has been 
shown to undergo asymmetric conformational changes in response to ATP binding (Hall, 
Shcherbakova et al. 2002; Tomer, Buermeyer et al. 2002).  The MMR system in 
eukaryotes has been reconstituted from human proteins and has been found to require 
MutSα or MutSβ, MutLα (but only for repair in the 3’ direction), ExoI, PCNA, HMGB1, 
RFC, RPA and DNA Polymerase δ (Constantin, Dzantiev et al. 2005; Zhang, Yuan et al. 
2005).  Because of its role in initiating MMR, many biochemical, biophysical and 
structural studies have been conducted on MutSα.  Fewer of those types of studies have 
been conducted on MutLα.   
MutLa 
Until recently, most of what was known about MutLα was based on similarities of 
MutLα to E. coli MutL.  It has been known that the ATPase activity of MutLα is 
necessary for MMR (Tran and Liskay 2000; Hall, Shcherbakova et al. 2002; Raschle, 
Dufner et al. 2002; Tomer, Buermeyer et al. 2002), and that MutLα is required for DNA 
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repair (Kramer, Kramer et al. 1989; Prolla, Christie et al. 1994), but until recently there 
wasn’t any known function for MutLα.  Kadyrov et al recently discovered an 
endonucleolytic activity in MutLα that is dependant on the presence of a mismatch, 
MutSα, PCNA, RFC and ATP (Kadyrov, Dzantiev et al. 2006).  The authors also found 
that the endonucleolytic activity of MutLα, believed to be located in the C-terminal 
domain of Pms2 (yPms1), is dependant upon the enzyme being proficient for ATP 
hydrolysis (Kadyrov, Dzantiev et al. 2006). 
Domain Organization of MutLα   
Both proteins that make up MutLα have a similar organizational scheme (Fig 
1.2).  The C-termini of both proteins in MutLα are responsible for dimerization (Pang, 
Prolla et al. 1997), and the C-terminus of Pms1 (hPms2) contains the metal binding 
residues required for endonucleolytic activity (Kadyrov, Dzantiev et al. 2006).   The N-
terminus of each protein contains an ATPase functionality as well as residues important 
to DNA binding (Tran and Liskay 2000; Hall, Wang et al. 2001; Drotschmann, Hall et al. 
2002; Hall, Shcherbakova et al. 2002; Raschle, Dufner et al. 2002; Tomer, Buermeyer et 
al. 2002).   Dimerization via the C-termini is not enough to facilitate MMR (Pang, Prolla 
et al. 1997); the ATPase activity is required for the mismatch repair action of the protein 
(Hall, Shcherbakova et al. 2003) as well as the endonucleolytic function (Kadyrov, 
Dzantiev et al. 2006).  The N- and C- terminal domains are connected by what is 
predicted to be a ~300 amino acid long flexible linker region (Jones 1999; McGuffin, 
Bryson et al. 2000; Bryson, McGuffin et al. 2005).   
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Figure 1.2:  General organization of MutLα.   
N- and C-terminal domains are predicted to have structure (represented by rounded 
rectangles), while the region connecting the two domains is predicted to be disordered.  
The N- terminal domain contains an ATPase activity, and is also able to bind DNA.  The 
C-terminal domain contains the residues required for dimerization, as well as the metal 
binding residues (in hPms2 or yPms1 only) required for the endonucleolytic activity. 
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For E. coli MutL, there are multiple crystal structures of N-terminal domain, and 
one of the C-terminal domain.  However, there is only one published crystal structure of a 
eukaryotic MutL homolog.  The N-terminal domain of hPms2 (homologous to yPms1) 
has been crystallized and solved with ADP, ATPγS and no nucleotide bound (Guarne, 
Junop et al. 2001).  The sequence and structural homology between MutL homologs (and 
even between eukaryotic and prokaryotic homologs) is primarily in their N-termini, 
which in all cases binds adenosine nucleotide using a set of four elements known as the 
Bergerat fold (Bergerat, de Massy et al. 1997; Guarne, Junop et al. 2001).  The Bergerat 
fold is a non-traditional ATP binding domain, unique to the GHL protein family (of 
which MutL and homologs are members) (Ban and Yang 1998; Ban, Junop et al. 1999; 
Dutta and Inouye 2000; Guarne, Junop et al. 2001; Hu, Machius et al. 2003). 
MutLα  and the GHL ATPase family 
In addition to MutL and MutL homologs, the GHL protein family includes two 
other namesakes, DNA Gyrase (and other type II topoisomerases, such as TopoVI) and 
Hsp90 (Figure 1.3) (Dutta and Inouye 2000). All members of the GHL ATPase family 
dimerize via their C-termini and bind ATP via the Bergerat fold, which is found in the N-
termini (Figure 1.3). 
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Figure 1.3 
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Figure 1.3:  Comparison of ATP binding pockets for 3 GHL ATPase family members. 
Crystal structures of the N-terminal domains of three GHL family members: MutL, Topo 
VI and yHsp82.  Each protein has ADP or non-hydrolyzable ATP analog bound.  Notice 
how the overall structures are similar:  β-sheets form the “back wall” of the ATP binding 
pocket; loops and α-helices form the sides and lid 
 
 
 
13 
The Bergerat fold consists of four motifs, I, II, III and IV (Figure 1.4).  Each 
motif contains a characteristic sequence: EXXXNXXD (Motif I), DXGXG (Motif II), 
GXXGXG/A (Motif III), and TXnGT (Motif IV) (Dutta and Inouye 2000).  The third 
motif, known as the “ATP lid”, changes conformation upon ATP binding, generally 
folding over the nucleotide once it is in the binding pocket made by the other three motifs 
(Bergerat, de Massy et al. 1997; Ban and Yang 1998; Ban, Junop et al. 1999; Dutta and 
Inouye 2000; Prodromou, Panaretou et al. 2000; Guarne, Junop et al. 2001; Pearl and 
Prodromou 2001; Corbett and Berger 2003; Immormino, Dollins et al. 2004; Corbett and 
Berger 2005; Dollins, Immormino et al. 2005; Shiau, Harris et al. 2006).  The ATP lid 
can move up to 20Å upon ATP binding from an open to a closed conformation (Figure 
1.4, compare light purple or light green (- adenine nucleotide) to dark purple or dark 
green (+ adenine nucleotide)).  In addition to Mg2+, a monovalent cation is required for 
ATP lid stabilization and ATP hydrolysis; the exception being Li+, which is believed to 
be too small to form the contacts necessary and ultimately inhibits ATP hydrolysis (Hu, 
Machius et al. 2003). 
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Figure 1.4: Close up of the four motifs that make up the ATP binding pocket (Bergerat 
fold) 
 The ATP binding pocket is shown for E. coli MutL & hPms2, each in the absence and 
presence of non-hydrolyzable ATP analog.  Motifs I, II & IV (blue, red and cyan, 
respectively) overlay well.  Motif III, the “ATP lid” changes conformation upon ATP 
binding in E. coli MutL (compare light purple to dark purple), and becomes disordered 
upon ATP binding in hPms2 (compare light green to dark green).  PDB id’s:  1B63, 
1BKN, 1H7S, 1H7U 
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Members of the GHL ATPase family have slow rates of ATP hydrolysis in the 
absence of other cofactors (0.4-0.9 min-1) (Ban, Junop et al. 1999; Dutta and Inouye 
2000; Spampinato and Modrich 2000; Guarne, Junop et al. 2001; Hall, Shcherbakova et 
al. 2002), suggesting that ATP hydrolysis in GHL family members, unlike other 
ATPases, is used more for signaling or conformational changes.   
Indeed, conformational changes in E. coli and yeast hsp90 proteins have been 
shown to occur as a result of ATP binding; these conformational changes are thought to 
be linked to the chaperoning of client proteins by the hsp90 family (Prodromou, 
Panaretou et al. 2000; Pearl and Prodromou 2001; Soti, Racz et al. 2002; Siligardi, Hu et 
al. 2004; Ali, Roe et al. 2006; Shiau, Harris et al. 2006).  Similarly, the timing of the 
passage of one strand of DNA through another by the type II topoisomerases (Topo VI, 
for example) is regulated by ATP hydrolysis (Corbett and Berger 2005).  
Cytidine Deaminases 
 Cytidine deaminases, as their name overtly suggests, deaminate cytidines to 
uracils.  One group of cytosine deaminases is the AID/APOBEC (activation induced 
cytidine deaminase / apolipoprotein B messenger RNA-editing enzyme catalytic 
polypeptide like) family.  The majority of the members of this family are catalytically 
active on RNA, but a few members (APOBEC3G and the activation induced cytosine 
deaminase AID) have been shown to be active on ssDNA (Petersen-Mahrt, Harris et al. 
2002; Dickerson, Market et al. 2003; Chelico, Pham et al. 2006).  
The AID/APOBEC family of proteins, which is active on RNA and ssDNA, 
belongs to the cytidine deaminase superfamily.  This superfamily contains a conserved 
zinc-binding signature motif, (H/C)(A/V)E(X24-30)(PCXXC), where X is any amino acid 
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(Navaratnam and Sarwar 2006); the cysteines and histidine coordinate a zinc ion, while 
the glutamate is involved in proton shuttling (Navaratnam and Sarwar 2006).  The 
ancestral members of this superfamily deaminate free bases (as opposed to those found in 
RNA or DNA sequences) and are either dimeric or tetrameric (Navaratnam and Sarwar 
2006).  Dimerization is often used in the cytidine deaminase superfamily to form the 
active site (Figure 1.5A) (Lau, Zhu et al. 1994; Xie, Sowden et al. 2004).  In contrast to 
other members of the superfamily, there is little known about the oligomeric state of AID, 
APOBEC2 and APOBEC3G, or how oligomerization affects function and cellular 
interactions.   
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Figure 1.5 
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Figure 1.5:  Two possible structures for proteins in the AID/APOBEC family.   
(A) Structure of the yeast protein CDD1 (PDB id: 1R5T), which deaminates free 
cytosines in solution.  Chains are shown in red, orange, green and blue.  Zinc ions (found 
in the active site) are represented by pink spheres.  (B) Structure of APOBEC2 (PDB id: 
2NYT), which has no known function.  This dimer of dimers is shown in blues and 
greens, with zinc ions represented by grey spheres. (Figure adapted from (Prochnow, 
Bransteitter et al. 2007)) 
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AID 
The activation induced cytidine deaminase AID is required for class switch 
recombination (CSR) and somatic hypermutation (SHM) (Muramatsu, Kinoshita et al. 
2000; Revy, Muto et al. 2000; Arakawa, Hauschild et al. 2002; Harris, Sale et al. 2002; 
Yang, Obiakor et al. 2005).  CSR and SHM are mechanisms that lead to the formation of 
high affinity antibodies characteristic of the secondary immune response.  AID 
deaminates cytidines, generating uracils in DNA that encodes the variable and the switch 
regions of the immunoglobulin locus (Petersen-Mahrt, Harris et al. 2002; Rada, Williams 
et al. 2002).  
In vitro, AID deaminates single-stranded but not double-stranded DNA 
(Bransteitter, Pham et al. 2003; Dickerson, Market et al. 2003; Pham, Bransteitter et al. 
2003; Sohail, Klapacz et al. 2003).  It has been shown that AID will function on dsDNA, 
but only if it is actively undergoing transcription, and especially if AID has been 
phosphorylated by PKA and is in complex with RPA (Chaudhuri, Khuong et al. 2004; 
Basu, Chaudhuri et al. 2005; Besmer, Market et al. 2006).  
AID preferentially deaminates microsequences associated with SHM hotspots 
(WGYW, where W = A or T, Y = Pyrimidine) (Bransteitter, Pham et al. 2003; Beale, 
Petersen-Mahrt et al. 2004; Bransteitter, Pham et al. 2004; Rogozin and Diaz 2004; Yu, 
Huang et al. 2004).  Data from pull-down assays using tagged-AID proteins and from 
structural modeling based on the free cytidine deaminases suggest that AID may function 
as a dimer to deaminate DNA (Ta, Nagaoka et al. 2003; Xie, Sowden et al. 2004; 
Prochnow, Bransteitter et al. 2007).  However, it remains unclear whether the active site 
of AID is at the dimer interface, or if AID monomers are catalytically active. 
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APOBEC2 
 APOBEC2 was found by sequence homology to other APOBEC proteins, and is 
found primarily in cardiac and skeletal muscle (Liao, Hong et al. 1999).  Unlike the other 
members of the AID/APOBEC family, APOBEC2 contains no deamination activity and 
its function remains unknown.  The crystal structure of APOBEC2 has been solved, and 
because of the 44.6% sequence homology between the crystallized APOBEC2 fragment 
and AID, this crystal structure is serving as a model for AID and other AID/APOBEC 
family members (Prochnow, Bransteitter et al. 2007; Zhang, Mangeat et al. 2007).   
The crystal structure of APOBEC2 (Prochnow, Bransteitter et al. 2007) (PDB id: 
2NYT) revealed that APOBEC2 exists as a dimer of dimers (Figure 1.5B). One dimer 
interface is made by the packing of two beta-sheets (one from each monomer); whereas 
the second dimerization interface, that of the tetramer, is weaker, and made by 
hydrophobic contacts, salt bridges and hydrogen bonding between loop regions 
APOBEC3G 
APOBEC3G, unlike APOBEC2, does have a known function and deamination 
activity.  This deamination activity is involved in viral immunity (Sheehy, Gaddis et al. 
2002; Nguyen, Gummuluru et al. 2007; Noguchi, Hiraga et al. 2007), with APOBEC3G 
deaminating cytidines in the viral transcript to eventually cause mutations.  These 
mutations eventually lead to the degradation of viral DNA (Sheehy, Gaddis et al. 2002).   
APOBEC3G interacts with the viral infectivity factor (Vif), an HIV protein, 
which targets APOBEC3G for proteosomal degradation.  In cells lacking Vif, 
APOBEC3G is able to survive, be packaged into the virion and deaminate cytidines in 
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the viral DNA.  APOBEC3G has been shown to act processively along ssDNA, with a 
preference for deaminating the third cytosine of -CCC- sequences (Chelico, Pham et al. 
2006). 
An enzymatically active, low molecular weight form of APOBEC3G exists in 
resting CD4+ T cells, which are resistant to HIV infection, while an enzymatically 
inactive, higher molecular weight form exists in activated CD4+ T cells, which happen to 
be susceptible to HIV infection (Chiu, Soros et al. 2005).  Treatment of the high 
molecular weight form of APOBEC3G with RNase converts it to the low molecular 
weight form (Chiu, Soros et al. 2005). These results suggest that the oligomeric state of 
APOBEC3G, and possibly other AID/APOBEC family members, may be related not only 
to deamination activity but also to interactions with other proteins. 
Atomic Force Microscopy 
Atomic force microscopy (AFM), also known as scanning force microscopy, was 
developed in 1986 from scanning tunneling microscopy. The advent of AFM enabled 
microscopic imaging of nonconductive, soft and live biological samples (Bustamante 
1995; Fotiadis, Scheuring et al. 2002).  With AFM, it is possible to view the 
topographical details on surfaces from the sub-molecular to the cellular level. AFM 
images can be collected in air and in solution, and for this reason, enables the study of 
dynamic processes of single molecules at physiologically relevant conditions.  Because of 
this wide range of applications, AFM is well suited to the imaging of biomolecules, 
biomolecular complexes, organelles and cells.   
AFM is a useful technique for the imaging of proteins, protein-protein and 
protein-DNA complexes.  Because of the deposition process (Figure 1.6) AFM images 
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collected in air provide a “snapshot” of the dynamic processes that are going on in the 
solution the sample was taken from.  A small volume of a sample containing protein 
and/or DNA is deposited directly onto mica.  At this point, the proteins and/or DNA that 
“stick” to the mica, by virtue of electrostatic interaction, will remain on the surface as the 
rest of the sample is washed away and the surface is dried.  In this process, the 
conformational state the proteins and/or DNA happened to be in upon deposition is the 
conformational state that they will remain in as the sample is imaged.  
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Figure 1.6 
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Figure 1.6:  Schematic of the deposition process for imaging a sample with AFM.   
A small volume of the sample (10-20 µL) is deposited directly onto freshly cleaved mica.  
The mica is then rinsed with ddH2O and dried with a gentle stream of nitrogen before 
being placed in the AFM for imaging.   
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Much information is contained in an AFM image.  For example, it is possible to 
estimate the oligomerization state of a protein based on its volume as measured by AFM, 
since a linear relationship between a protein’s molecular weight and its AFM volume has 
been shown (Ratcliff and Erie 2001; Yang, Wang et al. 2003).  Furthermore, the 
conformational effects of a protein binding to DNA (bending, wrapping, kinking) (Yang, 
Wang et al. 2003), as well as conformational changes within the protein itself can be seen 
directly.   
AFM images are generated when a sample of interest is scanned beneath a tip 
mounted on a cantilever (Figure 1.7A).  Forces of interaction between the tip and the 
sample, generated as the sample is scanned, cause deflections in the cantilever (Figure 
1.7B).  These deflections are monitored by a laser beam, which is reflected off the back 
of the cantilever into a 4-segment photodiode.  The photodiode is linked to the sample 
station (piezo) through a feedback loop, and the height of the piezo is adjusted to keep the 
clipping amplitude of the tip, monitored by the photodiode, constant (Figure 1.7C).  The 
change in height of the piezo is then plotted as a function of the X-Y position of the tip to 
yield a topographical image of the sample (Hansma, Sinsheimer et al. 1993; Bustamante 
1995).  (Figure 1.7D) 
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Figure 1.7 
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Figure 1.7:  Overview of how AFM works.   
(A) The sample is placed on a piezo, which is scanned in the x-y direction by a tip 
attached to a cantilever.  Laser light is reflected off of the back of the cantilever into a 
photodiode.  Throughout the scanning process the position of the reflected laser light on 
the photodiode is kept constant by a feedback loop between the photodiode and the piezo.  
(B) As the tip encounters something on the surface (protein, DNA, etc), it moves over it, 
causing the reflection of the laser light to change (dashed line).  (C)  To compensate for 
this change in the reflection, the piezo is moved down (compare grey lines to black lines), 
and this movement in the z-direction, when plotted against the x-y position yields a tree 
dimensional image (D), represented here in 2 dimensions with the third dimension (z) 
being represented by color.  This false color image (1 x 1 µm) has lower areas 
represented by darker colors, and higher areas represented by lighter colors
 
 
28 
Dissertation Overview 
 In the body of this work, AFM was the primary technique used to study protein 
conformational changes, oligomeric states, and, protein-DNA interactions.  In Chapter 2, 
the effect of adenine nucleotide on the conformation of MutLα is investigated.  In 
addition to using AFM, these studies also required the use of partial trypsin proteolysis 
and circular dichroism (CD).  The combination of these techniques reveals that MutLα 
can exist in one of four different conformational states, and ATP binding, but not 
hydrolysis mediates these conformational states.  Chapter 3 is an investigation into the 
oligomeric state of three cytidine deaminases, AID, APOBEC2 and APOBEC3G.  
Despite all three proteins being cytidine deaminases, they all have different oligomeric 
states, which may reflect on the different nature of their cellular function.  In Chapter 4, 
the effect of salt, ATP and the presence of a nick in DNA on the DNA binding and ATP 
hydrolysis of MutLα are investigated.  The preliminary data presented in this chapter 
suggest that ATP has a significant effect on the binding of yMutLα to covalently closed 
circular DNA and that the full-length yMutLα hydrolyzes ATP at a rate faster than the N-
terminal fragments of the protein.  Appendix A contains specific details on AFM imaging 
and the purification of yMutLα.
 
 
29 
References 
Ali, M. M., S. M. Roe, et al. (2006). "Crystal structure of an Hsp90-nucleotide-p23/Sba1 
closed chaperone complex." Nature 440(7087): 1013-7. 
Arakawa, H., J. Hauschild, et al. (2002). "Requirement of the activation-induced 
deaminase (AID) gene for immunoglobulin gene conversion." Science 295(5558): 
1301-6. 
Au, K. G., K. Welsh, et al. (1992). "Initiation of methyl-directed mismatch repair." J Biol 
Chem 267(17): 12142-8. 
Ban, C., M. Junop, et al. (1999). "Transformation of MutL by ATP binding and 
hydrolysis: a switch in DNA mismatch repair." Cell 97(1): 85-97. 
Ban, C. and W. Yang (1998). "Crystal structure and ATPase activity of MutL: 
implications for DNA repair and mutagenesis." Cell 95(4): 541-52. 
Basu, U., J. Chaudhuri, et al. (2005). "The AID antibody diversification enzyme is 
regulated by protein kinase A phosphorylation." Nature 438(7067): 508-11. 
Beale, R. C., S. K. Petersen-Mahrt, et al. (2004). "Comparison of the differential context-
dependence of DNA deamination by APOBEC enzymes: correlation with 
mutation spectra in vivo." J Mol Biol 337(3): 585-96. 
Bellacosa, A. (2001). "Functional interactions and signaling properties of mammalian 
DNA mismatch repair proteins." Cell Death Differ 8(11): 1076-92. 
Bergerat, A., B. de Massy, et al. (1997). "An atypical topoisomerase II from Archaea 
with implications for meiotic recombination." Nature 386(6623): 414-7. 
Besmer, E., E. Market, et al. (2006). "The transcription elongation complex directs 
activation-induced cytidine deaminase-mediated DNA deamination." Mol Cell 
Biol 26(11): 4378-85. 
Bransteitter, R., P. Pham, et al. (2004). "Biochemical analysis of hypermutational 
targeting by wild type and mutant activation-induced cytidine deaminase." J Biol 
Chem 279(49): 51612-21. 
Bransteitter, R., P. Pham, et al. (2003). "Activation-induced cytidine deaminase 
deaminates deoxycytidine on single-stranded DNA but requires the action of 
RNase." Proc Natl Acad Sci U S A 100(7): 4102-7. 
Bryson, K., L. J. McGuffin, et al. (2005). "Protein structure prediction servers at 
University College London." Nucleic Acids Res 33(Web Server issue): W36-8. 
Bustamante, C. a. K., D (1995). "Scanning Force Microscopy in Biology." Physics 
Today: 32-38. 
 
 
30 
Chaudhuri, J., C. Khuong, et al. (2004). "Replication protein A interacts with AID to 
promote deamination of somatic hypermutation targets." Nature 430(7003): 992-
8. 
Chelico, L., P. Pham, et al. (2006). "APOBEC3G DNA deaminase acts processively 3' --
> 5' on single-stranded DNA." Nat Struct Mol Biol 13(5): 392-9. 
Chiu, Y. L., V. B. Soros, et al. (2005). "Cellular APOBEC3G restricts HIV-1 infection in 
resting CD4+ T cells." Nature 435(7038): 108-14. 
Constantin, N., L. Dzantiev, et al. (2005). "Human mismatch repair: Reconstitution of a 
nick-directed bidirectional reaction." J Biol Chem. 
Corbett, K. D. and J. M. Berger (2003). "Structure of the topoisomerase VI-B subunit: 
implications for type II topoisomerase mechanism and evolution." Embo J 22(1): 
151-63. 
Corbett, K. D. and J. M. Berger (2005). "Structural dissection of ATP turnover in the 
prototypical GHL ATPase TopoVI." Structure (Camb) 13(6): 873-82. 
Dickerson, S. K., E. Market, et al. (2003). "AID mediates hypermutation by deaminating 
single stranded DNA." J Exp Med 197(10): 1291-6. 
Dollins, D. E., R. M. Immormino, et al. (2005). "Structure of unliganded GRP94, the 
endoplasmic reticulum Hsp90. Basis for nucleotide-induced conformational 
change." J Biol Chem 280(34): 30438-47. 
Drotschmann, K., M. C. Hall, et al. (2002). "DNA binding properties of the yeast Msh2-
Msh6 and Mlh1-Pms1 heterodimers." Biol Chem 383(6): 969-75. 
Drotschmann, K., W. Yang, et al. (2002). "Evidence for sequential action of two ATPase 
active sites in yeast Msh2-Msh6." DNA Repair (Amst) 1(9): 743-53. 
Dufner, P., G. Marra, et al. (2000). "Mismatch recognition and DNA-dependent 
stimulation of the ATPase activity of hMutSalpha is abolished by a single 
mutation in the hMSH6 subunit." J Biol Chem 275(47): 36550-5. 
Dutta, R. and M. Inouye (2000). "GHKL, an emergent ATPase/kinase superfamily." 
Trends Biochem Sci 25(1): 24-8. 
Fotiadis, D., S. Scheuring, et al. (2002). "Imaging and manipulation of biological 
structures with the AFM." Micron 33(4): 385-97. 
Guarne, A., M. S. Junop, et al. (2001). "Structure and function of the N-terminal 40 kDa 
fragment of human PMS2: a monomeric GHL ATPase." Embo J 20(19): 5521-31. 
Hall, M. C., P. V. Shcherbakova, et al. (2003). "DNA binding by yeast Mlh1 and Pms1: 
implications for DNA mismatch repair." Nucleic Acids Res 31(8): 2025-34. 
 
 
31 
Hall, M. C., P. V. Shcherbakova, et al. (2002). "Differential ATP binding and intrinsic 
ATP hydrolysis by amino-terminal domains of the yeast Mlh1 and Pms1 
proteins." J Biol Chem 277(5): 3673-9. 
Hall, M. C., H. Wang, et al. (2001). "High affinity cooperative DNA binding by the yeast 
Mlh1-Pms1 heterodimer." J Mol Biol 312(4): 637-47. 
Hansma, H. G., R. L. Sinsheimer, et al. (1993). "Recent advances in atomic force 
microscopy of DNA." Scanning 15(5): 296-9. 
Harris, R. S., J. E. Sale, et al. (2002). "AID is essential for immunoglobulin V gene 
conversion in a cultured B cell line." Curr Biol 12(5): 435-8. 
Hoffmann, E. R., P. V. Shcherbakova, et al. (2003). "MLH1 Mutations Differentially 
Affect Meiotic Functions in Saccharomyces cerevisiae." Genetics 163(2): 515-26. 
Hu, X., M. Machius, et al. (2003). "Monovalent cation dependence and preference of 
GHKL ATPases and kinases." FEBS Lett 544(1-3): 268-73. 
Immormino, R. M., D. E. Dollins, et al. (2004). "Ligand-induced conformational shift in 
the N-terminal domain of GRP94, an Hsp90 chaperone." J Biol Chem 279(44): 
46162-71. 
Iyer, R. R., A. Pluciennik, et al. (2006). "DNA mismatch repair: functions and 
mechanisms." Chem Rev 106(2): 302-23. 
Jones, D. T. (1999). "Protein secondary structure prediction based on position-specific 
scoring matrices." J Mol Biol 292(2): 195-202. 
Kadyrov, F. A., L. Dzantiev, et al. (2006). "Endonucleolytic function of MutLalpha in 
human mismatch repair." Cell 126(2): 297-308. 
Kramer, B., W. Kramer, et al. (1989). "Heteroduplex DNA correction in Saccharomyces 
cerevisiae is mismatch specific and requires functional PMS genes." Mol Cell 
Biol 9(10): 4432-40. 
Kunkel, T. A. and D. A. Erie (2005). "DNA mismatch repair." Annu Rev Biochem 74: 
681-710. 
Lau, P. P., H. J. Zhu, et al. (1994). "Dimeric structure of a human apolipoprotein B 
mRNA editing protein and cloning and chromosomal localization of its gene." 
Proc Natl Acad Sci U S A 91(18): 8522-6. 
Li, G. M. (2003). "DNA mismatch repair and cancer." Front Biosci 8: d997-1017. 
Liao, W., S. H. Hong, et al. (1999). "APOBEC-2, a cardiac- and skeletal muscle-specific 
member of the cytidine deaminase supergene family." Biochem Biophys Res 
Commun 260(2): 398-404. 
 
 
32 
Liu, T., H. Yan, et al. (2001). "The role of hPMS1 and hPMS2 in predisposing to 
colorectal cancer." Cancer Res 61(21): 7798-802. 
McGuffin, L. J., K. Bryson, et al. (2000). "The PSIPRED protein structure prediction 
server." Bioinformatics 16(4): 404-5. 
Modrich, P. and R. Lahue (1996). "Mismatch repair in replication fidelity, genetic 
recombination, and cancer biology." Annu Rev Biochem 65: 101-33. 
Muramatsu, M., K. Kinoshita, et al. (2000). "Class switch recombination and 
hypermutation require activation-induced cytidine deaminase (AID), a potential 
RNA editing enzyme." Cell 102(5): 553-63. 
Navaratnam, N. and R. Sarwar (2006). "An overview of cytidine deaminases." Int J 
Hematol 83(3): 195-200. 
Nguyen, D. H., S. Gummuluru, et al. (2007). "Deamination-independent inhibition of 
hepatitis B virus reverse transcription by APOBEC3G." J Virol 81(9): 4465-72. 
Noguchi, C., N. Hiraga, et al. (2007). "Dual effect of APOBEC3G on Hepatitis B virus." 
J Gen Virol 88(Pt 2): 432-40. 
Pang, Q., T. A. Prolla, et al. (1997). "Functional domains of the Saccharomyces 
cerevisiae Mlh1p and Pms1p DNA mismatch repair proteins and their relevance 
to human hereditary nonpolyposis colorectal cancer-associated mutations." Mol 
Cell Biol 17(8): 4465-73. 
Pearl, L. H. and C. Prodromou (2001). "Structure, function, and mechanism of the Hsp90 
molecular chaperone." Adv Protein Chem 59: 157-86. 
Petersen-Mahrt, S. K., R. S. Harris, et al. (2002). "AID mutates E. coli suggesting a DNA 
deamination mechanism for antibody diversification." Nature 418(6893): 99-103. 
Pham, P., R. Bransteitter, et al. (2003). "Processive AID-catalysed cytosine deamination 
on single-stranded DNA simulates somatic hypermutation." Nature 424(6944): 
103-7. 
Prochnow, C., R. Bransteitter, et al. (2007). "The APOBEC-2 crystal structure and 
functional implications for the deaminase AID." Nature 445(7126): 447-51. 
Prodromou, C., B. Panaretou, et al. (2000). "The ATPase cycle of Hsp90 drives a 
molecular 'clamp' via transient dimerization of the N-terminal domains." Embo J 
19(16): 4383-92. 
Prolla, T. A., D. M. Christie, et al. (1994). "Dual requirement in yeast DNA mismatch 
repair for MLH1 and PMS1, two homologs of the bacterial mutL gene." Mol Cell 
Biol 14(1): 407-15. 
 
 
33 
Rada, C., G. T. Williams, et al. (2002). "Immunoglobulin isotype switching is inhibited 
and somatic hypermutation perturbed in UNG-deficient mice." Curr Biol 12(20): 
1748-55. 
Raschle, M., P. Dufner, et al. (2002). "Mutations within the hMLH1 and hPMS2 subunits 
of the human MutLalpha mismatch repair factor affect its ATPase activity, but not 
its ability to interact with hMutSalpha." J Biol Chem 277(24): 21810-20. 
Ratcliff, G. C. and D. A. Erie (2001). "A novel single-molecule study to determine 
protein--protein association constants." J Am Chem Soc 123(24): 5632-5. 
Revy, P., T. Muto, et al. (2000). "Activation-induced cytidine deaminase (AID) 
deficiency causes the autosomal recessive form of the Hyper-IgM syndrome 
(HIGM2)." Cell 102(5): 565-75. 
Rogozin, I. B. and M. Diaz (2004). "Cutting edge: DGYW/WRCH is a better predictor of 
mutability at G:C bases in Ig hypermutation than the widely accepted 
RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine 
deaminase-triggered process." J Immunol 172(6): 3382-4. 
Sheehy, A. M., N. C. Gaddis, et al. (2002). "Isolation of a human gene that inhibits HIV-
1 infection and is suppressed by the viral Vif protein." Nature 418(6898): 646-50. 
Shiau, A. K., S. F. Harris, et al. (2006). "Structural Analysis of E. coli hsp90 Reveals 
Dramatic Nucleotide-Dependent Conformational Rearrangements." Cell 127(2): 
329-340. 
Siligardi, G., B. Hu, et al. (2004). "Co-chaperone regulation of conformational switching 
in the Hsp90 ATPase cycle." J Biol Chem 279(50): 51989-98. 
Sohail, A., J. Klapacz, et al. (2003). "Human activation-induced cytidine deaminase 
causes transcription-dependent, strand-biased C to U deaminations." Nucleic 
Acids Res 31(12): 2990-4. 
Soti, C., A. Racz, et al. (2002). "A Nucleotide-dependent molecular switch controls ATP 
binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding 
unmasks a C-terminal binding pocket." J Biol Chem 277(9): 7066-75. 
Spampinato, C. and P. Modrich (2000). "The MutL ATPase is required for mismatch 
repair." J Biol Chem 275(13): 9863-9. 
Ta, V. T., H. Nagaoka, et al. (2003). "AID mutant analyses indicate requirement for 
class-switch-specific cofactors." Nat Immunol 4(9): 843-8. 
Tomer, G., A. B. Buermeyer, et al. (2002). "Contribution of human mlh1 and pms2 
ATPase activities to DNA mismatch repair." J Biol Chem 277(24): 21801-9. 
 
 
34 
Tran, P. T. and R. M. Liskay (2000). "Functional studies on the candidate ATPase 
domains of Saccharomyces cerevisiae MutLalpha." Mol Cell Biol 20(17): 6390-8. 
Warren, J. J., T. J. Pohlhaus, et al. (2007). "Structure of the Human MutSalpha DNA 
Lesion Recognition Complex." Mol Cell 26(4): 579-92. 
Xie, K., M. P. Sowden, et al. (2004). "The structure of a yeast RNA-editing deaminase 
provides insight into the fold and function of activation-induced deaminase and 
APOBEC-1." Proc Natl Acad Sci U S A 101(21): 8114-9. 
Yang, G., H. Obiakor, et al. (2005). "Activation-induced deaminase cloning, localization, 
and protein extraction from young VH-mutant rabbit appendix." Proc Natl Acad 
Sci U S A 102(47): 17083-8. 
Yang, Y., H. Wang, et al. (2003). "Quantitative characterization of biomolecular 
assemblies and interactions using atomic force microscopy." Methods 29(2): 175-
87. 
Yu, K., F. T. Huang, et al. (2004). "DNA substrate length and surrounding sequence 
affect the activation-induced deaminase activity at cytidine." J Biol Chem 279(8): 
6496-500. 
Zhang, K. L., B. Mangeat, et al. (2007). "Model Structure of Human APOBEC3G." PLoS 
ONE 2: e378. 
Zhang, Y., F. Yuan, et al. (2005). "Reconstitution of 5'-directed human mismatch repair 
in a purified system." Cell 122(5): 693-705. 
 
 
 
CHAPTER 2 
ASYMMETRIC ADENINE NUCLEOTIDE INDUCED CONFORMATIONAL 
CHANGES IN MUTLα 
Introduction 
Eukaryotes, as well as some prokaryotes, have no known MutH homolog, and the 
sequence of events from mismatch recognition to repair for these organisms is not 
completely understood.  As such, the role of the eukaryotic MutL homolog, MutLα, is 
not fully known.  MutLα is a heterodimer comprised of Mlh1 and Pms2 (Pms1 in yeast) 
and contains a latent endonuclease activity that is activated in the presence of a 
mismatch, MutSα, PCNA, RFC and ATP (Kadyrov, Dzantiev et al. 2006).  In addition to 
this endonucleolytic activity, MutLα is able to suppress the activity of ExoI on 
homoduplex DNA (Jager, Rasmussen et al. 2001; Genschel and Modrich 2003; Nielsen, 
Jager et al. 2004), and it interacts with several other proteins in the MMR pathway (Jager, 
Rasmussen et al. 2001; Mendillo, Mazur et al. 2005; Kadyrov, Dzantiev et al. 2006; Lee 
and Alani 2006).  It has been proposed that conformational changes in MutLα caused by 
ATP binding and/or hydrolysis modulate these varying protein interactions during the 
repair process (Guarne, Junop et al. 2001; Raschle, Dufner et al. 2002).
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Like the homodimeric E. coli MutL (Guarne, Ramon-Maiques et al. 2004; 
Kosinski, Steindorf et al. 2005), each subunit in the heterodimeric MutLα contains a C-
terminal dimerization domain (Pang, Prolla et al. 1997) connected to an N-terminal 
ATPase domain (Pang, Prolla et al. 1997; Tran and Liskay 2000) via a linker region that 
is predicted to be disordered.  The ATPase activity of MutL and MutLα is required for 
MMR (Pang, Prolla et al. 1997; Spampinato and Modrich 2000; Tran and Liskay 2000; 
Hall, Shcherbakova et al. 2002; Raschle, Dufner et al. 2002) and is also required for the 
endonuclease activity in hMutLα (Kadyrov, Dzantiev et al. 2006). 
MutL and MutL homologs are members of the GHL ATPase family (Ban and 
Yang 1998; Ban, Junop et al. 1999; Dutta and Inouye 2000; Guarne, Junop et al. 2001; 
Hu, Machius et al. 2003), that is characterized by a non-traditional ATP binding fold 
(Bergerat, de Massy et al. 1997).  Other members of this family include the namesakes; 
DNA Gyrase and Hsp90 as well as Grp94 and the type II topoisomerases.  MutL and 
other GHL family members have been shown to have slow (0.4 min-1 – 0.9 min-1 ) rates 
of ATP hydrolysis in the absence of other cofactors (Ban, Junop et al. 1999; Dutta and 
Inouye 2000; Spampinato and Modrich 2000).  In all proteins in the GHL family, ATP 
binding and/or hydrolysis appears to induce large conformational changes which are 
purported to be involved in the signaling of cellular processes (Ban, Junop et al. 1999; 
Dutta and Inouye 2000; Corbett and Berger 2003; Immormino, Dollins et al. 2004; 
Corbett and Berger 2005; Dollins, Immormino et al. 2005; Ali, Roe et al. 2006; Chu, 
Maynard et al. 2006; Shiau, Harris et al. 2006). 
The conformational changes observed in E. coli MutL in response to adenine 
nucleotide have been previously explored indirectly by size-exclusion chromatography 
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and directly by crystallographic structures of the isolated N-terminal domain.  Size-
exclusion chromatography has shown that the full length E. coli MutL adopts a more 
compact size in the presence of a non-hydrolyzable ATP analog, AMPPNP, which the 
authors attribute to N-terminal dimerization (Ban, Junop et al. 1999).  Similarly, crystal 
structures of the N-terminal domain of E. coli MutL show that AMPPNP binding results 
in the dimerization of the N-terminal domains, which is distinct from the monomeric   
crystal structure of the apo enzyme (Ban, Junop et al. 1999).  The crystal structure of the 
AMPPNP bound form of E. coli MutL also shows that upon AMPPNP binding, the ATP 
lid of the Bergerat fold folds over and makes contacts with the AMPPNP. 
In stark contrast to E. coli MutL, the N-terminal fragment of hPms2, one of two 
subunits in eukaryotic MutLα, is a monomer in the crystal structure, even in the presence 
of an ATP analog.   Unlike E.coli MutL, the N-terminal fragment is hydrolytically 
proficient, and dimerization appears to not be a requirement for ATP hydrolysis (Guarne, 
Junop et al. 2001).  Additionally, the ATP lid of the Bergeral fold actually becomes more 
disordered, and fewer residues of this lid are seen in the ATPγS structure than in the apo 
structure.  To date, there are no data on the full-length structures of either MutL or 
MutLα. 
In this chapter an analysis of the full-length structure of MutLα at the level of 
individual molecules is presented.  Using AFM coupled with biochemical analyses, the 
nucleotide-induced changes in the quaternary structure of human and yeast MutLα are 
investigated.  AFM images reveal that MutLα can adopt four distinct conformations.  
Based on the observed conformational changes, a model for how ATP binding and 
hydrolysis drives conformation changes in MutLα is proposed.  These observed 
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conformational changes are likely coupled to the signaling of downstream events in 
mismatch repair. 
Results 
MutLα  Exists in Four Different Conformational States 
Inspection of AFM images such as those in Figure 2.1A reveals that yMutLα can 
adopt four different conformational states.  In the absence of additional nucleotide 
cofactors, MutLα exists primarily in an open and “v-shaped” extended conformation, in 
which a large compact central domain is connected to two smaller domains by flexible 
arms (Figure 2.1B and Figure 2.1F).  Because it is known that yMlh1 and yPms1 form 
the heterodimeric complex via their C-termini (Pang, Prolla et al. 1997), the larger 
structure found at the vertex of the V is undoubtedly the dimerized C-termini, while the 
two domains located at the ends of the elongated linker arms are the N-termini.   
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Figure 2.1 
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Figure 2.1: AFM images of yMutLα. 
(A) 500 nm x 500 nm images of MutLα deposited in the absence of nucleotide (left) and 
in the presence of 5 mM ADP (right). Arrows point to examples of the four different 
conformational states seen in the images: red = extended; blue = one armed; orange = 
semi-condensed; green = condensed. Scale bar (white) is 250 nm. (B-E) 100 nm x 100 
nm images of the four states accompanied by cartoons of MutLα in the different 
conformational states. In the cartoons, domains are indicated by ovals, connected by a 
flexible linker. Disordered linker is shown as a dashed line; ordered linker is shown as a 
heavy line. Mlh1 is shown in light green and blue, and Pms2 (yPms1) is shown in dark 
green and blue. (F) a selection of 100 nm x 100 nm images of the extended state to show 
the flexibility of the linker arms 
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A statistical analysis of these extended conformations revealed that one arm is 
approximately 40% longer than the other and a broad distribution of angles between the 
two arms (Figure 2.2 and Table 2.1).  These results are consistent with secondary 
structure predictions made using PsiPred and PONDR (Jones 1999; McGuffin, Bryson et 
al. 2000; Bryson, McGuffin et al. 2005), which suggest that the N- and C- terminal 
domains of yMlh1 and yPms1 have well defined secondary structures that are connected 
by disordered regions of ~160 and ~300 amino acids, respectively.  The flexible linker 
arms have a smaller cross-section than the coiled-coil domains of Rad50 as visualized by 
AFM (van Noort, van Der Heijden et al. 2003), further reinforcing the idea that the arms 
that connect the N- and C-termini lack secondary structure.  Finally, the volume of 
proteins in AFM images has been shown to depend linearly on molecular weight (Ratcliff 
and Erie 2001; Yang, Wang et al. 2003; Yang, Sass et al. 2005), and the measured 
volumes of the three observed domains are consistent with the predicted molecular 
weights of the structured N-termini and dimerized C-terminal domains (Tables 2.2 and 
2.3). 
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Figure 2.2: Distribution of angles formed between the two arms of MutLα in the extended 
conformation 
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Short Arm Length Long Arm Length Angle between the Two 
21.68 ± 6.44 nm 30.00 ± 8.05 nm 110.75 ± 33.93 ° 
 
Table 2.1:  Average arm length and angles of MutLα  in the extended conformation.  
Lengths and angles were measured by hand (n=63).  Lengths were measured from the 
edge of one domain to the edge of the other domain.  Angles were measured by 
estimating a vertex in the center of the dimerized C-termini and then drawing lines from 
the vertex parallel with where the arm exited the dimerized C-termini. 
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Table 2.2: Predicted molecular weights & volumes for domains in yMutLα.  
Molecular weights are based on PSIPRED & PONDR predictions for domain size.  For 
the C•C•N structures, the linker belonging to the condensed N terminal domain is 
included in the predicted MW & volume calculations.  For the C•C•N•N structure, both 
linker arms are included in the calculation. 
 Predicted 
C•C 56 kDa  
52.5 nm3 
NMlh1 37 kDa 
29.7 nm3 
NPms1 40 kDa 
33.3 nm3 
C•C•NMlh1 112 kDa 
119.7 nm3 
C•C•NPms1 130 kDa 
141.3 nm3 
C•C•N•N 
(full length 
protein) 
186 kDa 
208.5 nm3 
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 v-shape 
(n=10) 
One-arm 
(n=11) 
Semi-condensed & 
condensed (n=24) 
C•C 90.9 ± 15.4 nm3   
N 42.9 ± 11.6  nm3 43.2 ± 12.3 nm3  
C•C•N  137.7 ± 25.5 nm3  
C•C•N•N   213.7 ± 42.4 nm3 
 
Table 2.3:  Actual measured volumes (in nm3) of C•C, N, C•C•N and C•C•N•N 
structures. 
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In addition to the extended conformation, three other minor populations of 
conformations are seen in the AFM images (Figures 2.1 & 2.3).  Approximately 20% of 
the molecules exhibit a “one armed” conformation, with a large domain connected to a 
smaller one by a flexible linker arm (Figure 2.1C).  Measurement of the volume of the 
domains (Ratcliff and Erie 2001; Yang, Wang et al. 2003; Yang, Sass et al. 2005) reveals 
that the large structure in this state is larger than the central structure in the extended 
conformation (Table 2.3).  These results suggest that in these one-armed conformations, 
one of the N-terminal domains is either interacting directly with the dimerized C-terminal 
region and/or that one linker arm has folded (“condensed”) to create a globular domain 
consisting of the two C-termini, one linker arm, and one N-terminus.  Roughly 10% of 
the molecules are in a semi-condensed state, with two domains similar in size (Figure 
2.1D).  In this state, the linker arms are not visible and the centers of the two domains are 
separated by 15 ± 4 nm.  These results suggest that in this state, the two N-terminal 
domains have associated with one another but not with the C-terminal domains.  The 
semi-condensed state is distinguished from the one-armed state by the size of the protein 
domains and their relative orientations to each other.  Finally, ~ 15% of the molecules 
exhibit a compact structure with no protrusions (condensed state, Figure 2.1E).  In this 
condensed state, the N- and C-terminal domains of both proteins in the heterodimer 
appear to be interacting to form a single compact molecule with no visible separate 
domains or linker arms visible. 
 
 
 
47 
 
 
Figure 2.3: Distribution of yMutLα molecules among each of the four states under 
varying conditions.  
apo (n=727), 0.1 mM ADP (n=912), 0.1 mM ATP (n=391), 5 mM ADP (n=559), and 5 
mM ATP (n=1021). Red = extended; Blue = one-arm; Orange = semi-condensed; Green 
= condensed. Data were tallied by hand from 1 x 1 µm AFM images taken from multiple 
experiments. 
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Adenine nucleotides induce large conformational changes in MutLα  
Genetic studies have shown that mutations that impair the binding or hydrolysis 
of ATP in either yPms1 or yMlh1 result in defective MMR in vivo (Tran and Liskay 
2000; Hall, Shcherbakova et al. 2002).  In addition, biochemical studies suggest that ATP 
binding and hydrolysis induce conformational changes in MutL homologs (Ban and Yang 
1998; Tran and Liskay 2000; Hall, Shcherbakova et al. 2002; Raschle, Dufner et al. 
2002).  To assess the role of adenine nucleotides in controlling the conformations of 
MutLα, we imaged MutLα under a variety of nucleotide conditions (Figure 2.3).  Based 
on previous studies of the ATPase activities of the N-terminal domains of yMlh1 and 
yPms1 (Hall, Shcherbakova et al. 2002), we chose conditions in which we expected 
either only the ATPase site of Mlh1 to be occupied (0.1 mM) or both sites to be occupied 
(5 mM). 
Addition of either 0.1 mM ATP or ADP results in a decrease in the population of 
molecules in the extended conformation and increase in the population of the one-armed 
state (Figure 2.3).  These results suggest that binding of ADP or ATP promotes a 
conformation of MutLα in which the N-terminal domain and linker arm of Mlh1 or Pms1 
is interacting with or folded onto the C-terminal dimerization domains of Mlh1 and/or 
Pms1.  Because Mlh1 appears to have a higher affinity for ATP (Hall, Shcherbakova et 
al. 2002), it is likely that these conformational changes are occurring in Mlh1 rather than 
Pms1.  
At high concentrations of ATP (5 mM) where both yMlh1 and yPms1 should 
have nucleotide bound, MutLα exists predominately in the condensed conformation 
(70%) (Figure 2.3).  Similar results were obtained with 1 mM ATP (data not shown).  
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These results indicate that binding and/or hydrolysis of ATP drives the formation of this 
highly compact state in which the N-termini are interacting with one another and with the 
linker arms and/or the C-terminal dimerization domains.  Interestingly, high 
concentrations of ADP (5 mM) also cause a significant increase in the condensed state 
(40% versus 15% without nucleotide).  These results suggest that occupancy of both of 
the ATPase sites with either ATP or ADP facilitates the formation of the condensed state, 
although ATP is more efficient than ADP. 
Proteolysis Protection reveals ATP-induced structural changes in solution 
 To further assess these conformational changes, we used partial proteolysis to 
probe MutLα conformations in solution (Figure 2.4).  Consistent with our AFM results 
and previous experiments using hMutLα (Raschle, Dufner et al. 2002), yMutLα is 
readily digested by trypsin in the absence of nucleotide cofactor.  The addition of 5 mM 
ATP, and to a lesser extent 0.1 mM ATP, results in the protection of MutLα (especially 
Mlh1) from protease digestion (Figure 2.4).  These results indicate that ATP induces a 
conformational change that masks the trypsin protease sites and supports the idea that the 
conformational changes observed by AFM also occur in solution. 
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Figure 2.4: Partial trypsin proteolysis of yMutLα.  
From left to right: undigested yMutLα, digested yMutLα, digested yMutLα + 0.1 mM 
ATP, digested yMutLα + 5 mM ATP 
 
 
51 
ATP binding causes an increase in secondary structure 
 Although the AFM data reveal that ATP can induce dramatic changes in the 
conformation of MutLα and the partial proteolysis data suggest conformational changes, 
neither technique provides direct information about secondary structure formation.  To 
determine if ATP binding promotes the formation of structure in the flexible arms, we 
examined secondary structure formation using circular dichroism spectroscopy (CD).  
Due to the high extinction coefficient of ATP, we were able to only obtain CD spectra at 
0.1 mM ATP (but not at 5 mM ATP).  At this concentration of ATP, there is a significant 
increase in the one-armed state in the AFM images and a slight increase in the amount of 
protein protected from trypsin digestion.  Comparison of the CD spectra in the absence 
and presence of 0.1 mM ATP (Figure 2.5) shows that the addition of 0.1 mM ATP causes 
a significant increase in the CD signal in the region centered at 225 nm.  This negative 
peak, centered at 225 nm, is characteristic of α-helices and/or β-sheet secondary 
structures in proteins (Kelly, Jess et al. 2005).  There is also a positive peak, centered at 
260 nm, that is consistent with a rigid environment for aromatic amino acid residues 
(Kelly, Jess et al. 2005). These data, taken together with our AFM data, and partial 
proteolysis results, suggest that binding of ATP to one subunit of MutLα (probably 
Mlh1) induces the formation of secondary structure, likely in the flexible linker arm, and 
promoting the interaction between a linker arm and the N- and C- termini. 
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Figure 2.5: CD spectra of 0.4 µM yMutLα in the absence (red) and presence (blue) of 0.1 
mM ATP.  
The signal differences seen at 220-230 nm demonstrate that in the presence of ATP, the 
protein adopts more secondary structure (either α-helix or β-sheet). Plotted curves are the 
average of 3 experiments, with the background spectra (either imaging buffer alone or 
imaging buffer + 0.1 mM ATP) subtracted. 
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Human MutLα  displays similar conformational changes 
 To determine if the results with yeast MutLα are general, we examined the 
conformations of human MutLα (hMlh1-hPms2) alone, with 0.1 mM ATP and with 5 
mM ATP.  As expected, we observe the same four states for hMutLα that we see for 
yMutLα.  In addition, the distributions of the states under the same conditions are similar 
for hMutLα and yMutLα (Figure 2.6).  Specifically, in the absence of ATP, both yeast 
and human MutLα exist predominantly in the extended state with defined N- and C- 
termini and disordered linker arms; whereas, in the presence of 5 mM ATP, both human 
and yeast MutLα are primarily condensed.  There are some differences in the 
distributions in the presence of 0.1 mM ATP, which may result from differences in the 
ATP binding affinity of the yeast and human proteins (Figure 2.6), since very little is 
known about the binding affinity of any full-length eukaryotic MutLα.   
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Figure 2.6 
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Figure 2.6: Comparison of the distributions of conformational states of hMutLα and 
yMutLα molecules.  
hMutLα apo (n=1253), hMutLα + 0.1 mM ATP (n=979), hMutLα + 5 mM ATP (n=302). 
Red = extended; blue = one-arm; orange = semi-condensed; green = condensed. Data 
were tallied by hand from 1 x 1 µm AFM images taken from multiple experiments.
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Hydrolysis is not required for the formation of the condensed state 
To determine whether or not hydrolysis of ATP is required for the formation of 
the condensed state, we examined the conformational changes of a mutant of hMutLα in 
which the hydrolysis activity of both subunits is severely impaired (hMlh1•E34A-
Pms2•E41A (hMutLα-EA)).  In this mutant, the conserved glutamate residues in the 
active sites of both subunits have been changed to alanines, inhibiting hydrolysis of ATP 
(Raschle, Dufner et al. 2002; Tomer, Buermeyer et al. 2002).  Images of hMutLα-EA in 
the absence of adenine nucleotide appear similar to images of the wild-type human and 
yeast MutLα, with the extended conformation dominating the population significantly 
(Figure 2.7A).  In addition, like wild-type MutLα, high concentrations of ATP (5mM) 
cause hMutLα-EA to condense (Figure 2.7B and 2.7C).   
The hMutLα-EA mutant is still capable limited ATP hydrolysis, with a rate of 
~0.2 min-1 (Raschle et al., 2002; F.K and P.M. unpublished results).  Because MutLα and 
ATP are incubated together for less than a minute prior to being deposited on the surface, 
less than 20% of the hMutLα-EA molecules will have hydrolyzed ATP at the time of 
deposition.  Given that ~70% of the molecules are in the condensed state for both the 
wild-type hMutLα and hMutLα-EA, it is highly unlikely that hydrolysis is required for 
formation of the condensed state (Figure 2.7C).  
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Figure 2.7 
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Figure 2.7: Comparison of hydrolysis-deficient experimental conditions.   
Comparison of hMutLα-EA in the absence (A) and presence (B) of 5 mM ATP. Both are 
500 x 500 nm scans; hMutLα concentration is 30 nM. Arrows point out individual 
molecules in the v-shaped (A) and condensed (B) state.  Distribution of MutLa molecules 
among each of the four states.  apo yMutLα (n=727), yMutLα + 5 mM ATP (n=1021), 
yMutLα + Na•AMPPNP (n=213), hMutLα•EA + 5mM ATP (n=161). Red = extended; 
blue = one-arm; orange = semi-condensed; green = condensed. Data were tallied by hand 
from 1 x 1 µm AFM images taken from multiple experiments. 
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To further investigate the role of ATP hydrolysis, we imaged yMutLα in the 
presence of the non-hydrolyzable ATP analog 5’-adenylyl-beta-gamma-
imidodiphosphate (AMPPNP).  In our initial experiments, we used AMPPNP as 
purchased from Sigma which comes as a tetralithium salt, and we found that it did not 
promote the condensation of MutLα, which is in direct contrast to the results obtained 
using the hMutLα-EA hydrolysis mutant.  Because LiCl, in the absence of other salts, has 
been shown to inhibit the ATPase activity of GHL ATPases (Hu, Machius et al. 2003), 
we added 20mM LiCl to our 5 mM ATP reactions and found that it inhibited the 
formation of the condensed state (data not shown).  Consequently, we purified the 
commercially available AMPPNP using an ion exchange column and eluted it using Na+ 
(see materials & methods) to for the sodium salt (Na•AMPPNP).  Depositions of yMutLα 
in the presence of Na•AMPPNP show that ~55% of the molecules are in the condensed 
state (Figure 2.7C).  These results, taken together with the data on hMutLα-EA, strongly 
suggest that ATP binding, but not hydrolysis, is required to induce the formation of the 
fully condensed state. 
 
Discussion 
X-ray crystallography is a good technique for the indirect visualization of 
structured proteins and protein domains.  However, there are no full-length structures of 
MutL or MutLα, likely because of the intrinsic disorder of the linker connecting the N- 
and C- termini as well as the large conformational changes that take place upon adenine 
nucleotide binding.  AFM imaging has allowed us to not only visualize the protein in four 
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different conformational states but also to visualize the linker arm, which is unlikely to be 
detected with other techniques. 
Nucleotide binding induces conformational changes and disorder-order transitions in 
MutLα  
Our experiments show that in the absence of added adenine nucleotide, MutLα 
exists predominantly in an extended conformation (Figures 2.1 & 2.3).  In this extended 
conformation, there are no visible interactions between the N- and C- terminal domains 
or between the two N-terminal domains of the heterodimer.  There is likely no ATP 
bound to this dominating extended state, nor to the other, lesser-populated states.  
The binding of one ATP to MutLα, likely to Mlh1 (KM = 69 µM in an N-terminal 
construct of yMlh1 vs. KM = 1500 µM in an N-terminal construct of yPms1) (Hall, 
Shcherbakova et al. 2002), drives the formation of the one-armed state.  The one-armed 
state shows an increase in secondary structure compared to the extended state, as 
observed by CD in the absence (extended) and presence of 0.1 mM ATP (one-arm) 
(Figure 2.5).  In addition, Mlh1 is slightly less sensitive (1.5 to 2-fold) to trypsin than 
Pms1 under all conditions (Figure 2.4 and data not shown).  Taken together, these results 
suggest that binding of ATP to Mlh1 promotes secondary structure formation in its linker 
arm condensing the N-terminus of Mlh1 onto the dimerized C-terminal domains.   
We also show that 5 mM ATP (or ADP), where both nucleotide-binding sites 
should be occupied, causes a condensation of both subunits in the heterodimer.  In the 
condensed state, the interactions between linker regions and the N- and C-termini likely 
persist, with the addition of interactions between the two N-termini.  The observation that 
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the hydrolysis mutant, hMutLα-EA, condenses in the presence of ATP strongly suggests 
that condensation is linked to binding of adenine nucleotide but not to ATP hydrolysis. 
The semi-condensed state is likely a conformational rearrangement of the 
condensed state, with the contacts between the two N-termini remaining, but with the 
linker regions partially unfolded and no interaction between the N-termini and C-termini.  
This state suggests direct interaction between the two N-termini in MutLα.  The presence 
of all four of these states in the absence of adenine nucleotide suggests that the four 
protein states are in dynamic equilibrium and that binding and hydrolysis of ATP 
followed by ADP release drive MutLα into the different conformational states. 
The observed ordering of the previously disordered regions in MutLα upon ATP 
binding is analogous to the ordering that happens after ligand binding in intrinsically 
disordered proteins (Dunker, Lawson et al. 2001; Xie, Vucetic et al. 2007; Xie, Vucetic et 
al. 2007).  Although ATP binding alone is unlikely to induce order in the ~160 and ~300 
disordered amino acids in the linker arms, it probably promotes interactions of the linker 
regions with the other regions of MutLα, such as the C-terminal domains, and these 
interactions, together with the ATP binding may lead to the significant increase in 
secondary structure that is observed in the CD spectra.  As such, this disorder-order 
transition adds another class of such transitions to natively disordered proteins (Dunker, 
Lawson et al. 2001; Xie, Vucetic et al. 2007; Xie, Vucetic et al. 2007) where binding of a 
small molecule to one region of a protein, which is predominately ordered, allosterically 
promotes the folding of an adjacent region of the protein. 
 
 
62 
Comparison of MutLα  with other GHL ATPases 
The members of the GHL ATPase family are diverse in their function.  Despite 
this diversity of function, there remains a common theme: the binding and subsequent 
hydrolysis of ATP drives protein conformational changes that are linked to the timing of 
their mechanistic cycles (Ban, Junop et al. 1999; Dutta and Inouye 2000; Corbett and 
Berger 2003; Immormino, Dollins et al. 2004; Corbett and Berger 2005; Dollins, 
Immormino et al. 2005; Ali, Roe et al. 2006; Chu, Maynard et al. 2006; Shiau, Harris et 
al. 2006).  Reflective of this common theme, the overall architectures of proteins in the 
GHL ATPase family are similar; the N-terminus contains a conserved ATPase binding 
domain and the C-terminus contains a varying dimerization domain (Dutta and Inouye 
2000).  One of the sources of variation between GHL proteins is in the connection 
between the N- and C- domains.  Most GHL proteins have a structured middle domain; 
whereas, MutLα contains large disordered regions between the N- and C- terminal 
domains, which were previously predicted (Guarne, Ramon-Maiques et al. 2004) and 
confirmed by this study. 
In spite of the functional differences between the MutLα and the other GHL 
family members, the four states observed here show similarity to conformational states of 
Grp94 and HtpG which have been studied using electron microscopy (EM) and/or x-ray 
crystallography (Wearsch and Nicchitta 1996; Shiau, Harris et al. 2006).  Grp94 and 
HtpG have ordered middle domains (in comparison with the disordered linker of MutLα) 
and no one-armed state has been observed for Grp94 or HtpG.  
In the absence of adenine nucleotide, both Grp94 and HtpG are seen by EM in an 
extended, v-shaped, conformation very similar to the extended conformation seen here 
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for MutLα by AFM.  The difference between the extended MutLα and extended Grp94 
and HtpG is the absence of the disordered linker arms connecting N- and C-termini in 
Grp94 and HtpG.  In the presence of the non-hydrolyzable ATP analog AMPPNP, HtpG 
undergoes a large conformational change from the open, extended state to a more 
compact state (Shiau, Harris et al. 2006).  This state appears similar to the semi-
condensed state of MutLα seen by AFM (Figure 2.1D), with the N-termini dimerized, but 
not collapsed upon the C-termini.  When visualized by EM in the presence of ADP, HtpG 
becomes even more condensed than it is in the presence of AMPPNP.  
 Examination of the crystal structures of HtpG in the absence and the presence of 
ADP along with the structure of yHsp82, the yeast homolog of Hsp90, shows that the 
Hsp90 proteins also exist in an extended conformation in the absence of ATP (Ali, Roe et 
al. 2006; Shiau, Harris et al. 2006).  The addition of ADP causes dimerization of the N-
terminal domains (seen with HtpG), while the addition of ATP causes a twisted collapse 
around the dimerized N-terminal domains (seen with yHsp82) and a 20 Å movement of 
the N-terminal domains towards each other (Ali, Roe et al. 2006).  Perhaps the semi-
condensed structure we visualize by AFM is an “untwisted” version of the condensed 
state.  
ATPase cycle for MutLα  
Each of the four observed states of MutLα is a snapshot of the conformational 
changes involved in the process of ATP binding, hydrolysis and ADP release.  Based on 
these four observed states, one possible model for an ATPase cycle suggests that adenine 
nucleotides bind sequentially to MutLα  (Figure 2.8).  The model is consistent with 
different KMs of the N-terminal domains of yMlh1 and yPms1 (Hall, Shcherbakova et al. 
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2002).  The extended state corresponds to MutLα with no nucleotide bound (apo). The 
binding of the first ATP condenses one “arm”, likely Mlh1, forming the one-armed state; 
the binding of a second ATP condenses the other arm, forming the condensed state.   
The one-armed state is formed by the ordering of the linker region of one protein 
in MutLα, causing it to condense into the already dimerized C-termini.  The occurrence 
of this state suggests that there may be contacts formed between the N- and C- terminal 
domains in MutLα after ATP binds to the protein.   Partial proteolysis suggests that these 
interactions are dynamic, because the digestion patterns of yMutLα alone and yMutLα 
plus 0.1 mM ATP are similar (Figure 2.4).  
The hydrolysis and subsequent release of both bound adenine nucleotides, either 
sequentially (following the one-armed pathway) or at the same time (following the semi-
condensed pathway), returns the protein to the original extended conformation.  Because 
high ADP concentration also drive the formation of the condensed state, it is likely that 
ADP release, not ATP hydrolysis, causes the cycling of the protein through the four 
states.  As the cycle progresses, conformational changes expose different surfaces and 
new structured regions to solution, making them available for binding by other proteins.   
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Figure 2.8: ATPase cycle for MutLα.  
The extended state corresponds to MutLα with no nucleotide bound (apo). The binding 
of the first ATP condenses one “arm” (probably Mlh1), forming the one-armed state; the 
binding of a second ATP condenses the other arm (Pms2), forming the condensed state. 
The hydrolysis and release of both bound adenine nucleotides, either sequentially 
(following the one-armed pathway) or at the same time (following the semi-condensed 
pathway), returns the protein to the extended conformation. 
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Our model contrasts with a previously proposed ATPase cycle for MutL that was 
based upon mutational studies alongside biochemical and crystallographic data (Ban, 
Junop et al. 1999).  In the E. coli MutL model, both MutL monomers bind ATP at the 
same time, followed by N-terminal dimerization.  Each MutL monomer then 
simultaneously hydrolyzes ATP, the N-terminal domains dissociate and ADP is released.  
The extended state we observe for the eukaryotic MutLα correlates well with the N-
terminal dissociated state seen for MutL, while the semi-condensed state correlates with 
the dimerized N-terminal state.   
However, MutLα is a heterodimer, and each protein contained therein has 
differing ATP affinities and rates of ATP hydrolysis.  These important differences make 
simultaneous ATP binding and hydrolysis unlikely for the subunits of MutLα.  As we 
have observed in the one-armed state, the condensation of one protein subunit (after the 
binding of one ATP) occurs in the absence of the condensation of the other. 
MutLα  conformational changes in the context of MMR and cellular activities 
 It has long been suggested that MutL and MutL homologs function as a switch or 
molecular matchmaker, changing conformation to coordinate the functions of the 
mismatch repair machinery.  In this paper, we report direct observations of 
conformational changes to MutLα in response to adenine nucleotide.  ATP hydrolysis is 
required for repair (Pang, Prolla et al. 1997; Spampinato and Modrich 2000; Tran and 
Liskay 2000; Hall, Wang et al. 2001; Raschle, Dufner et al. 2002) as well as the 
endonucleolytic activity of MutLα (Kadyrov, Dzantiev et al. 2006).  Since MutLα also 
interacts with PCNA and ExoI in the MMR pathway, perhaps our observed 
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conformational changes mediate the timing of these interactions as well as the enzymatic 
function of MutLα.    
The in vivo concentrations of ADP and ATP (~1 mM and ~3 mM, respectively) 
(Williams, Fulton et al. 1993) suggest that MutLα would rarely exist in the apo form 
unless this form is stabilized by other proteins.  It has been demonstrated that interactions 
between MutSα and MutLα are mediated by the N-terminal domain of Mlh1 alone and 
are not linked to the ATPase activity of MutLα (Raschle, Dufner et al. 2002; Plotz, 
Raedle et al. 2003).  Since the ATPase activity of MutLα does not affect interactions with 
MutSα, MutSα may be able to interact with MutLα in any conformational state, but to do 
so, MutSα must be in the appropriate state.   
Stable complexes containing MutSα, MutLα, PCNA, mismatched DNA and ATP 
have been observed in vitro (Dzantiev, Constantin et al. 2004; Hidaka, Takagi et al. 2005; 
Lee and Alani 2006); (Constantin, Dzantiev et al. 2005; Zhang, Yuan et al. 2005).  Based 
on observed in vitro interactions and on in vivo ATP concentrations, MutLα is likely in 
the condensed state when interacting with MutSα and PCNA.  With the subsequent 
hydrolysis of one or both bound ATP molecules, the protein likely changes from the 
condensed state to the semi-condensed and/or apo state, changing the surface of MutLα 
and possibly hiding the surface with which PCNA interacts, exposing the ExoI 
interaction surface.  Once ADP and Pi are released into solution, MutLα will be “reset” 
and ready to participate in another round of mismatch repair.  The time required to 
hydrolyze ATP and then release ADP and Pi, as well as the time required for 
conformational changes likely causes a “pause” in the process of mismatch repair, 
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allowing for the proteins currently interacting with MutLα to complete their intended 
processes.   
As mentioned in the introduction, the proteins that make up MutLα also 
participate in other DNA transactions.  The conformational changes reported here may 
mediate protein-protein interactions in those cellular activities as well. 
Materials & Methods 
Chemicals 
 ATP, ADP and AMPPNP were purchased from Sigma. 
Protein Expression and Purification 
 yMutLα was purified as previously described (Hall and Kunkel 2001), with the 
exception of HEPES, pH 7.3 being used in the dialysis buffer instead of Tris, pH 7.3.  
hMutLα and hMutLα-EA were purified as described (Kadyrov, Dzantiev et al. 2006). 
Atomic Force Microscopy 
 For AFM imaging, yMutLα, hMutLα or hMutLα-EA was diluted to a final 
concentration of 30 nM in imaging buffer (20 mM HEPES, pH 7.3, 5 mM MgOAc, 
25mM NaOAc) at room temperature.  A volume of 10 µl of the diluted protein was 
deposited onto freshly cleaved ruby mica (Spruce Pine Mica Company, Spruce Pine, 
NC).  The sample was rinsed immediately with nanopure water; excess water was blotted 
from the surface and the surface was then dried using a stream of nitrogen. 
 For experiments where ATP, ADP or AMPPNP (Na•AMPPNP) were present, the 
adenine nucleotide and MutLα were mixed and then diluted in imaging buffer to a final 
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adenine nucleotide concentration of 0.1 mM, 1 mM or 5 mM and protein concentration of 
30 nM.  The sample was then deposited as for MutLα protein alone.  The sample 
preparation and deposition process (from addition of adenine nucleotide to drying of 
sample) took ~1 minute. 
AFM images were captured in air using either a Nanoscope III or IIIa (Digital 
Instruments, Santa Barbara, CA) microscope in tapping mode.  Pointprobe Plus tapping 
mode silicon probes (Agilent Technology, Tempe, AZ) with resonance frequencies of 
approximately 170 kHz were used for imaging.  Images were collected at a speed of 2-3 
Hz with an image size of 1 µm at 512 x 512 pixel resolution.  
 Images were analyzed using Nanoscope III v5.12r3 software (Veeco, Santa 
Barbara, CA), Image SxM, v 1.69 (Barrett 2006) and NIH ImageJ (Rasband 1997-2006) 
with OpenAFM and Cell Counter plug-ins.  Volume analysis was performed as 
previously described (Ratcliff and Erie 2001; Yang, Wang et al. 2003).  Statistical plots 
were generated with Kaleidagraph (Synergy Software, Reading, PA). 
Purification of AMPPNP 
 A 1 mL HiTrap DEAE column (GE Biosciences) was prepared according to 
manufacturers instructions.  AMPPNP was dissolved in ddH2O (0.5 mL; final 
concentration 0.1 M) and loaded onto the column by syringe.  The column was washed 
with ten column volumes of ddH2O, and the AMPPNP was eluted with 0.25 M NaCl 
(~100 µL fraction size).  The AMPPNP eluted in the first three fractions (after the 1 mL 
column volume came off), and was pooled. 
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Circular Dichroism Spectropolarimetry 
 CD spectra (λ = 210-300 nm) of 0.4 µM yMutLα in imaging buffer in the 
presence and absence of 0.1 mM ATP were acquired on an AVIV spectropolarimeter at 
10oC, with 2 nm resolution and an averaging time of 3 sec per point, in 1-cm quartz 
cuvettes.  Plotted curves are the average of 3 experiments, with the background spectra 
(either imaging buffer alone or imaging buffer + 0.1 mM ATP) subtracted out. 
Partial Proteolysis 
 In experiments testing for protease protection, 5 ng of trypsin was added to 
reactions containing 8 µg of yMutLα alone and with 0.1 mM ATP or 5 mM ATP in 
imaging buffer.  The reaction was allowed to proceed for 5 minutes at room temperature 
before stopping the reaction by the addition of SDS load and incubation at 95°C for 10 
minutes.  All reactions were then run on a 10% SDS-PAGE gel.  Protein bands were 
visualized by staining with Coomassie Brilliant Blue R-250. 
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 CHAPTER 3 
CYTIDINE DEAMINASES 
Introduction 
 Unlike the rest of this dissertation, the work contained within this chapter deals 
with proteins designed to make mutations in DNA, not avoid them. This chapter focuses 
on the oligomeric states of three members of the AID/ABOBEC family of proteins, AID, 
APOBEC2 and APOBEC3G.  Members of the AID/APOBEC family of proteins (AID = 
activation induced cytosine deaminase; APOBEC = apolipoprotein B mRNA-editing 
enzyme, catalytic polypeptide-like) have been shown to deaminate cytidines found in 
RNA or ssDNA to uracils in the process of innate and adaptive immunity, including 
somatic hypermutation (SHM). 
 The AID/APOBEC family of proteins belongs to the cytidine deaminase 
superfamily.  The ancestral members of this superfamily deaminate free bases (as 
opposed to those found in RNA or DNA) and are either dimeric or tetrameric.  
Dimerization is often used in the cytidine deaminase superfamily to form the active site.  
In contrast to their forefathers, there is little known about the oligomeric state of the 
members of the AID/APOBEC family.   
 AID 
The cytidine deaminase, AID, is required for class switch recombination (CSR) 
and somatic hypermutation (SHM), two antigen-activated mechanisms that lead to the 
formation of isotype-switched, high affinity antibodies characteristic of the secondary 
immune response (Muramatsu, Kinoshita et al. 2000; Revy, Muto et al. 2000; Arakawa, 
Hauschild et al. 2002; Harris, Sale et al. 2002; Yang, Obiakor et al. 2005).  AID 
deaminates cytidines, generating uracils in DNA encoding the variable and the switch 
regions of the immunoglobulin locus (Petersen-Mahrt, Harris et al. 2002; Rada, Williams 
et al. 2002).  
In vitro, AID deaminates single-stranded but not double-stranded DNA 
(Bransteitter, Pham et al. 2003; Dickerson, Market et al. 2003; Pham, Bransteitter et al. 
2003; Sohail, Klapacz et al. 2003).  It has been shown that AID will function on dsDNA, 
but only if it is actively undergoing transcription, especially if AID has been 
phosphorylated by PKA and is in complex with RPA (Chaudhuri, Khuong et al. 2004; 
Basu, Chaudhuri et al. 2005; Besmer, Market et al. 2006). 
AID preferentially deaminates microsequences associated with SHM hotspots 
(WGYW, where W = A or T, Y = Pyrimidine) (Bransteitter, Pham et al. 2003; Beale, 
Petersen-Mahrt et al. 2004; Bransteitter, Pham et al. 2004; Rogozin and Diaz 2004; Yu, 
Huang et al. 2004).  Data from pull-down assays using tagged-AID proteins and from 
structural modeling based on the free cytidine deaminases suggest that AID may function 
as a dimer to deaminate DNA (Ta, Nagaoka et al. 2003; Xie, Sowden et al. 2004; 
Prochnow, Bransteitter et al. 2007).  However, it remains unclear whether the active site 
of AID is at the dimer interface, or if AID monomers are catalytically active. 
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APOBEC2 
 APOBEC2 was found by sequence homology to other APOBEC proteins, and is 
found primarily in cardiac and skeletal muscle (Liao, Hong et al. 1999).  Unlike the other 
members of the AID/APOBEC family, APOBEC2 contains no deamination activity and 
its function remains unknown.  Despite this lack of enzymatic activity, the crystal 
structure of APOBEC2 has been solved, and because of the 44.6% sequence homology 
between the crystallized APOBEC2 fragment and AID, this crystal structure serves as a 
model for other AID/APOBEC family members (Prochnow, Bransteitter et al. 2007; 
Zhang, Mangeat et al. 2007).   
The crystal structure of APOBEC2 (Prochnow, Bransteitter et al. 2007) (PDB id: 
2NYT) revealed that APOBEC2 exists as a dimer of dimers. One dimer interface is made 
by the joining of two sets beta-sheets (one from each monomer) (Figure 5.1A); whereas 
the second dimerization interface is made by hydrophobic packing, salt bridges and 
hydrogen bonding (Figure 5.1B).  
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Figure 3.1:  Illustration of dimer (A) and tetramer (B) interfaces for APOBEC2 (PDB ID 
2NYT).   
Monomers of APOBEC2 are shown in blues and greens; zinc ions are shown as pink 
spheres; red dashed lines show dimerization and tetramerization interfaces. 
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APOBEC3G 
APOBEC3G works to inhibit the infectivity of viruses like HIV and Hepatitis B, 
presumably by deaminating cytosines to generate uracils, eventually targeting viral DNA 
for degradation (Sheehy, Gaddis et al. 2002; Nguyen, Gummuluru et al. 2007; Noguchi, 
Hiraga et al. 2007).  Interaction of the HIV Viral infectivity factor protein (Vif) with 
APOBEC3G targets APOBEC3G for degradation via the proteosomal pathway.  In Vif-
deficient cells, however, APOBEC3G is able to survive and deaminate cytosines in the 
viral DNA, causing mutations in and eventual degradation of the viral DNA (Sheehy, 
Gaddis et al. 2002).  APOBEC3G has been shown to act processively along ssDNA, with 
a preference for deaminating the third cytosine of -CCC- sequences (Chelico, Pham et al. 
2006). 
Results 
AFM, which yields topographic images of molecules deposited on a surface, has 
proven to be a powerful tool for determining the oligomerization state of proteins as well 
as protein-protein association constants (Ratcliff and Erie 2001; Xue, Ratcliff et al. 2002; 
Bao, Wang et al. 2003; Yang, Wang et al. 2003; Tessmer, Moore et al. 2005; Yang, Sass 
et al. 2005).  It has been demonstrated that the volume of a protein or protein complex as 
measured by AFM exhibits a linear dependence on the molecular weight of proteins 
(Equation 3.1), where V is the volume as measured by AFM and MW is the molecular 
weight of the protein (Ratcliff and Erie 2001; Yang, Wang et al. 2003). 
 
Equation 3.1  V = 1.2(MW) – 14.7 
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Using this relationship, the oligomerization states for many different proteins and protein-
protein complexes have been determined in the presence and absence of DNA (Ratcliff 
and Erie 2001; Yang, Wang et al. 2003; Tessmer, Moore et al. 2005; Yang, Sass et al. 
2005). 
AID 
AID deaminates DNA loops and bubbles embedded in double-stranded DNA 
To examine the deamination activity of AID on various single-stranded DNA 
substrates including substrates containing loops or bubbles, and to determine substrates 
for AFM analysis, we designed oligonucleotides containing the structures depicted in 
Figure 3.2.  Deamination reactions were done for the various substrates following the 
scheme depicted in Figure 3.2A. AID deaminated all substrates tested, including the loop 
and bubble substrates, but not double-stranded DNA (Figures 3.2B and C).  The best 
substrate for AID is the L-oligo, modeled after the oligonucleotide designed by Yu and 
colleagues (Yu, Huang et al.), with over 50% deamination after 15 minutes, followed by 
the single-stranded oligonucleotide modeled after V regions of human IgV heavy chains 
(over 40% deaminated product at 15 minutes) (Figure 3.2C).  Even at high protein 
concentrations, in the single-stranded oligonucleotide that contains multiple dC’s 
throughout its length, the majority of product is deaminated at or near the site resembling  
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Figure 3.2:  AID deaminates single-stranded DNA in various configurations.  
(A) Schematic representation of deamination reaction and expected product following 
incubation of end-labeled oligonucleotide with AID and UDG. (B) AID deaminates most 
oligonucleotides where single-stranded DNA (ssDNA) is exposed but fails to deaminate 
double-stranded DNA (dsDNA), (C) Quantitation of autoradiographs after deamination 
reactions. The substrate devoid of secondary structure (L-oligo) deaminated best but there 
was substantial deamination of loop structures over time. All reactions contained 2 nM 
oligonucleotide and 500 nM AID protein and were repeated at least three times.  
(experiments done by S. Brar) 
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AID-mediated immunoglobulin somatic hypermutation hotspots (AGCA) (Figures 3.2b 
and 3.3), as seen previously by us and other groups (Bransteitter, Pham et al. 2003; Beale, 
Petersen-Mahrt et al. 2004; Bransteitter, Pham et al. 2004; Rogozin and Diaz 2004; Yu, 
Huang et al. 2004).  Although the substrate containing a single-stranded 8-nucleotide 
loop is not deaminated as rapidly as the single-stranded oligonucleotides, its deamination 
is significantly faster than that of the substrate containing a 10-nucleotide bubble. For 
example, after a 15 minute incubation with AID, greater than 20 % of the loop substrate 
was deaminated while only 11% of the bubble substrate was deaminated (Figure 3.2C).  
Deamination of single-stranded hairpin loops was consistently better than that of double-
stranded loops, regardless of the size of the loops, at all concentrations of protein and 
DNA tested (data not shown).  This lower rate of deamination of bubble substrates 
probably results from formation of non-canonical base pairs in the loop, thereby 
disrupting the accessibility of the cytidine to AID (Chou, Chin et al.). Taken together, 
these results indicate that AID preferentially deaminates cytosines that are maximally 
exposed.  This preference for single-stranded vs. double-stranded loops may reflect AID 
catalyzed-deamination of exposed single-stranded DNA in hairpin loops that might be 
formed due to the palindromic sequences often associated with CSR regions (Tashiro, 
Kinoshita et al.) or single-stranded DNA regions formed during transcription. 
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Figure 3.3:  Predicted structures and sequences of substrates used for deamination 
assays and AFM imaging 
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AID exists as a monomer in the absence of DNA 
We have used atomic force microscopy to determine the oligomerization state of 
AID.  Figure 3.4A shows representative AFM images of AID in the absence of DNA 
substrate. To determine the oligomerization state of AID, the volumes of each protein as 
seen by AFM were determined from a large number of images. In the absence of DNA, a 
distribution of volumes shows a single peak at ~15 nm3 (Figure 3.4C, black bars).  This 
volume is consistent with the predicted volume of 15 nm3 for a monomer of His-tagged 
AID (AID monomer MW = 24.8kDa).   
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Figure 3.4   
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Figure 3.4: AFM data on AID in the absence and presence of ssDNA substrate.  
All AFM images are 500 x 500 nm; scale bars (white) represent 250 nm. (A) 
representative AFM scan of AID in the absence of ssDNA. (B) Representative AFM scan 
of RNaseA-pretreated AID in the presence of L-oligo. (C) Volume analysis of AID.  
Black bars represent AID in the absence of substrate.  Grey bars represent RNase-
pretreated AID in the presence of L-oligo 
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A very small fraction of molecules have volumes corresponding to the predicted 
volume of a dimer of AID (45 nm3). Increasing the protein concentration from 5 nM to 
20 nM or incubating at 500nM and diluting to 10 nM only immediately before deposition 
(see methods) did not increase the population of species with larger volumes (data not 
shown).  These results indicate that AID exists predominantly as a monomer at these 
concentrations and suggests that any dimeric form would be transient, and have a 
relatively weak association constant (Ratcliff and Erie 2001; Yang, Wang et al. 2003). 
AID exists primarily as a monomer in the presence of substrate DNA 
To determine if ssDNA induces dimerization, AID was incubated with 10nM to 
50nM of the L-oligo for 30 minutes before deposition.  The concentrations of AID 
protein and oligonucleotide used in these AFM experiments are within the range of 
concentrations where significant deamination of substrate by AID after 30 minutes of 
incubation is observed. 
Since RNA co-purifies with AID, and the removal of RNA (usually with 
RNaseA) is necessary for the activation and deamination activity of AID (Bransteitter, 
Pham et al. 2003), we considered the possibility that bound RNA might interfere with 
dimerization and/or DNA binding.  To test this possibility, we pre-incubated AID with 
RNaseA for 30 minutes before adding the L-oligo, and then imaged as usual (Figure 
3.4B).  To assure that AID was active under these conditions, the deamination activity of 
AID when preincubated with RNaseA for 30 minutes versus adding RNaseA at the start 
of the deamination assay was tested.  As seen previously, RNaseA was required for 
deamination to occur, however, pre-incubation with RNaseA did not change the rate of 
deamination.  
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The concentration of AID was 20-fold higher than that of RNaseA so that 
RNaseA would only be a minor population (5 %) of the protein in the AFM images. The 
distribution observed for AID that has been pre-treated with RNaseA and then incubated 
with L-oligo is indistinguishable from that of AID that was not pre-treated with RNaseA 
and incubated with the L-oligo (Figure 3.4C, grey bars and data not shown).  The major 
peak in the distribution is found at ~18 nm3.  This peak, while still corresponding to 
monomeric AID, is shifted to a slightly higher volume compared to AID in the absence of 
oligonucleotide (Figure 3.4C, compare black bars to grey bars).  This increase in volume 
in the presence of oligonucleotide is consistently seen for both AID treated and untreated 
with RNaseA, and it likely represents oligonucleotide being bound to monomeric AID.  
These results suggest that binding of DNA to AID does not induce the dimerization of 
AID, since there is no significant increase in the fraction of peaks with volumes 
corresponding to the dimer (~45 nm3) in the presence of DNA substrate. 
AID can deaminate single-stranded DNA as a monomer 
 To determine if AID can function as a monomer, we measured the rates of 
deamination of the L-oligo substrate (100 nM) at low concentrations of AID (5 nM and 
20nM), where our AFM data indicate that AID is primarily monomeric (Fig. 3.4C).  For 
5 nM and 20 nM AID with 100 nM oligonucleotide, the initial rates (determined by linear 
fits to the data for timepoints ≤ 30 minutes) are 0.12 min-1 and 0.54 min-1, respectively 
(Figure 3.5a).  This increase in rate (4.5-fold) is within error of the expected increase for 
the 4-fold increase in enzyme concentration (Segel).  These results strongly suggest that 
AID can function as a monomer to deaminate cytosine in single-stranded DNA.   
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 To assure that this observed activity was due the monomer and not to a small 
population of dimers seen in the AFM images (less than 20% of the population has 
volumes that could be attributed to the dimer in the presence of oligo), we examined the 
rates of deamination of 10 nM L-oligo with 2-fold (20 nM) and 50-fold (500 nM) excess 
AID.  If a small fraction of AID dimers were responsible for the observed activity, we 
would expect to see an increase in deamination rate with increasing AID concentration 
from 20 nM to 500 nM, because at 20 nM AID, the dimer concentration (20% of the 
population corresponds to ~ 3nM AID dimer) would be well below the DNA 
concentration.  Consequently, if the dimer were responsible for the observed activity, we 
should see and increase in deamination activity upon increasing the AID concentration 
from 20 to 500 nM, as we observed for the experiments with the DNA in excess (Figure 
3.5a).  Inspection of Figure 3.5b reveals that the rate of deamination is the same for both 
of these concentrations.  These results indicate that at 10 nM L-oligo, a two-fold excess 
of AID is sufficient to bind all of the L-oligo and catalyze deamination.  This result is 
consistent with the measured binding affinities of AID for oligonucleotide substrates, 
which are in the sub to low nanomolar range (Larijani, Petrov et al.).  Taking these 
kinetic data together with the AFM data strongly support the conclusion that AID is 
functional as a monomer on single-stranded DNA in vitro. 
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Figure 3.5 
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Figure 3.5:  Deamination rate when AID is in limiting (A) or excess (B) 
These data indicate that most of the catalysis on single-stranded DNA oligonucleotide is 
from the monomer.  A) Rate of deamination of 100 nM L-oligo in the presence of 5 nM 
(squares) and 20 nM (circles) AID.  The straight lines are linear fits to data points for 
times ≤ 30 minutes.  The initial rates were determined from the linear fits.  B) Rate of 
deamination of 10 nM L-oligo in the presence of 20 nM (squares) and 500 nM (circles) 
AID.  The curves are first order exponential fits to the data.  The error bars represent the 
standard error from 3 or more experiments. (experiments done by S. Brar) 
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APOBEC2 
APOBEC2 exists primarily as a dimer 
To investigate the oligomerization state of APOBEC2, we imaged APOBEC2 at 
concentrations of 40 nM (Figure 3.6A). Volume analysis done on the AFM scans at 40 
nM show that APOBEC2 is primarily a dimer (Figure 3.6B).  The major peak from these 
data is at ~30 nm3, which is consistent with the molecular weight of a dimer (36.4 kDa) 
of the APOBEC2 fragment used in these studies.  Our AFM results are in contrast to the 
crystal structure of APOBEC2, which showed APOBEC2 as a long, rod-shaped tetramer.  
Had APOBEC2 existed as a long, rod-shaped tetramer, it would have been visible in the 
AFM scans in one of two ways.  The first is if the protein were “standing on end” on the 
mica.  If this had been occurring, the protein peaks would have been both very tall and 
narrow. The other possibility is if the rod-shaped tetrameric protein were “laying down 
on its side”, in which case the proteins observed would have been short, but wide in one 
dimension.  Since neither of these theoretical forms were observed, nor were volumes 
consistent with that of a tetramer, we can conclude that the protein does not exist as a 
tetramer under the conditions of these AFM experiments. 
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Figure 3.6: AFM data on APOBEC2.   
(A) Representative AFM image of APOBEC2. AFM image is 500 x 500 nm, scale bar 
(white) represents 250 nm.  (B) volume analysis of APOBEC2 
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APOBEC3G 
APOBEC3G exists as a multimer of dimers 
 To investigate the oligomeric state of APOBEC3G, we imaged the protein at a 
concentration of 20nM in the presence and absence of a ssDNA substrate containing two 
sequences that APOBEC3G preferentially acts upon.   APOBEC3G exists as multimers 
of dimers (Figure 3.7A & 3.7B).  In the absence of DNA, the major volume peak is 
centered at ~75 nm3, which correlates with the predicted volume of an APOBEC3G 
dimer (90.9 nm3; predicted volume of monomer = 38.1 nm3).  The other peaks seen in the 
volume analysis (Figure 3.7B) correlate well with the predicted volumes of APOBEC3G 
tetramers (196.5 nm3), hexamers (302.1 nm3) and octamers (407.7 nm3).   
 In the presence of ssDNA (Figure 3.7C), APOBEC3G seems to follow a similar 
trend as it has in the absence of ssDNA, except the peaks in volume analysis have been 
shifted to slightly higher volumes (Figure 3.7D), presumably because of the binding of 
ssDNA substrate. 
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Figure 3.7 
 
 
97 
Figure 3.7:  AFM data on APOBEC3G in the presence and absence of ssDNA substrate.  
All AFM images are 500 x 500 nm; scale bars (white) represent 250 nm. (A) 
Representative AFM scan of APOBEC3G in the absence of ssDNA substrate.  (B) 
volume analysis of APOBEC3G in the absence of DNA substrate.  (C) Representative 
AFM scan of APOBEC3G in the presence of equimolar ssDNA substrate (D) volume 
analysis of APOBEC3G in the presence of ssDNA substrate.  
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Discussion 
AID 
We found that AID is catalytically active as a monomer on single-stranded DNA 
in vitro, even when the single-stranded DNA region is embedded in double-stranded 
DNA in the form of loops. We did not observe a significant population of volumes 
consistent with AID dimers by AFM for any of the protein/oligo concentrations, 
including concentrations where well over 50% of the oligo is deaminated (Figure 3.4C, 
data not shown).  Pre-incubation of AID at concentrations up to 500nM also failed to 
alter the percentage of volumes corresponding to the dimer.  In addition, even when we 
examined deamination at protein concentrations ranging from exceedingly low (barely 
detectable deamination) to in large excess over oligonucleotide concentrations, the rate of 
deamination by AID on single-stranded DNA substrates was not substantially changed 
with increasing AID concentration (Figure 3.6). While these results demonstrate that AID 
is active as a monomer on single-stranded DNA in vitro, they do not preclude the 
possibility that AID may also function as a dimer in vivo where it may be post-
translationally modified via phosphorylation (Basu, Chaudhuri et al.). 
Comparison of the rates of deamination on single-stranded DNA loops within 
double-stranded DNA with deamination rates on substrates devoid of any secondary 
structure such as the L-oligo indicates that even short loops of single-stranded DNA can 
be deaminated by AID relatively well, albeit with less efficiency than DNA sequences in 
which the cytidine is expected to be completely exposed, such as the L-oligo (Figures 3.2 
& 3.3). These results imply that even at low concentrations, as found in the nucleus of 
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cells expressing AID, monomeric AID could catalyze the deamination of cytidine to 
uracil as long as it can find a suitable substrate in the form of exposed single-stranded 
DNA patches or loops. In support of this idea, recent data suggests that AID can bind and 
deaminate single-stranded DNA in a variety of configurations such as displaced single-
stranded DNA loops or patches (Duquette, Pham et al.; Yu, Roy et al.; Larijani, Petrov et 
al.; Ronai, Iglesias-Ussel et al.), and even in negatively supercoiled double-stranded 
DNA (Shen and Storb) formed during transcription. These results might explain why 
AID can access and deaminate DNA in non-natural substrates such as in DNA of E. coli 
cells, non-lymphoid cells, and non-Ig genes that are actively transcribed (Martin and 
Scharff 2002; Petersen-Mahrt, Harris et al. 2002; Yoshikawa, Okazaki et al. 2002; 
Okazaki, Hiai et al. 2003), and wherein B-cell specific post-translational modifications of 
AID do not occur. If for example, dimerization is optimally promoted when AID is 
specifically phosphorylated in activated B cells, these results imply that non-
phosphorylated monomeric AID in other cells could potentiate inappropriate deamination 
of dC in non-immunoglobulin gene targets. It will be interesting to determine whether 
monomeric AID contributes to non-targeted AID-mediated deamination in B cell 
lymphomas or when expressed in non-B cells.  If so, the oligomeric status of AID may 
contribute yet another layer of regulation similar to transcriptional regulation and 
intracellular localization that keep cells expressing AID from experiencing its mutagenic 
activity in non-intended targets (Brar, Watson et al.; Ito, Nagaoka et al.; McBride, 
Barreto et al.). In addition it is likely that, in B cells, targeting co-factors sharpen AID’s 
substrate specificity uniquely to the Ig V and CSR regions (Shinkura, Ito et al.), although 
these putative co-factors have yet to be identified.  
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Our results do not imply that the dimer does not form or is not functional. In the 
AFM images, a few percent of the molecules have volumes that correspond to the dimer 
and other higher order oligomeric states; increasing the concentration of AID from 5 nM 
to 20 nM, or depositing the sample following incubation at 500nM, does not result in any 
detectable changes in the population of molecules with higher volumes.  However, It is 
clear from our studies that in vitro that: a) the monomer is the predominant species in the 
absence of substrate, b) the monomer is catalytically active on single-stranded DNA, and 
c) binding to single-stranded DNA substrate does not induce any significant dimerization.   
A recent study that examined the binding of GST-tagged and His-tagged AID 
supports our conclusion that AID can function as a monomer.  Specifically, in band-shift 
assays of AID with a DNA substrate containing a single-stranded bubble, the GST-
tagged-AID, which is forced to be a dimer by GST dimerization (Dirr, Reinemer et al.), 
causes dramatically greater shifts of the DNA than does the His-tagged-AID, consistent 
with His-tagged-AID binding to DNA as a monomer. 
A recent report by Wang and colleagues, suggests that AID dimerization is 
required for optimal class switch recombination in vivo; however, these studies examined 
co-immunoprecipitation of AID with two different tags from cell extracts, and therefore, 
the apparent dimerization in these studies could be dimerization mediated by other 
proteins and not a direct interaction of two AID molecules (Wang, Shinkura et al.).  In 
addition, whether or not this “dimerization” is also required for immunoglobulin 
hypermutation where deamination of dC’s throughout the length of the V region is 
evident was not tested. Several other reasons may account for the differences between our 
results and those reported in the previous study (Wang, Shinkura et al.). Namely, we have 
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found that in its most proximal activity, as a deaminase, monomeric AID can deaminate 
dC’s in vitro, whereas class switch recombination in vivo, may require a higher order 
oligomeric state of AID to help align specific dC’s in switch regions or for other 
functionalities. Also, it is possible that AID acts both as a monomer and as a dimer in 
vivo, perhaps differentially for hypermutation and class switch recombination; a 
hypermutation phenotype was not reported in that study for the dimer mutants.  While 
both of these processes require AID, they also likely require different co-factors, occur 
independently of each other, and target different regions of the heavy chain Ig locus.  
Finally, it is conceivable that phosphorylation or other post-translational modifications of 
AID in activated B cells may promote dimerization, while the non-modified form of AID 
acts as a monomer, with less efficiency. In fact, ectopically expressed AID is not 
phosphorylated and yet it can deaminate dC in non-lymphoid cells, but at a lower 
frequency (Martin and Scharff 2002; Petersen-Mahrt, Harris et al. 2002; Yoshikawa, 
Okazaki et al. 2002; Okazaki, Hiai et al. 2003; Chaudhuri, Khuong et al. 2004). 
The observation that AID exhibits catalytic activity as a monomer in vitro is in 
contrast to other deaminases studied to date, including the RNA editing enzymes such as 
Apobec-1, and the adenosine deaminases (Lau, Zhu et al. 1994; Cho, Yang et al. 2003; 
Gallo, Keegan et al. 2003; Ko, Lin et al. 2003). Interestingly, these deaminases require 
dimerization not only for their enzymatic activity but also for specificity of the substrate. 
For example, homodimers comprising a wild type monomer and a mutant monomer of 
ADAR1 or ADAR2 lose only half the ability to deaminate a non-specific dsRNA 
substrate, in a sequence-independent manner but lose nearly 70% site-selective activity 
on natural substrates, such as the RNA encoding serotonin 2C subtype receptor (Cho, 
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Yang et al.).  Consequently, it is possible that while monomeric AID is catalytically 
active, a homodimer may confer some kind of substrate specificity wherein interaction 
between the monomers helps align a specific cytosine residue for deamination. This idea 
is interesting because deamination of cytosine in an RNA target would require exquisite 
targeting not only to a particular RNA species, but a particular cytosine in its sequence. 
Such a level of specificity may require dimerization as seen with RNA editing enzymes 
such as Apobec-1 (Lau, Zhu et al.). However, an RNA target for AID has not been 
identified although indirect evidence supports the possibility (Honjo, Muramatsu et al.).  
Alternatively, an AID homodimer, while not required for deamination, may help 
the simultaneous deamination of cytosine on both DNA strands, as previously suggested 
(Bransteitter, Pham et al.), an idea supported by our findings predicting that each 
monomer of AID in a putative dimer can catalyze deamination of single-stranded DNA 
independently. Additional support for this notion comes from structural analysis of AID 
suggesting that for the homodimer, both monomers are able to catalyze deamination 
independently on a double-stranded DNA or RNA substrate (Xie, Sowden et al.).  In 
addition, a recent structure of the AID homolog APOBEC2 shows that while APOBEC2 
is a dimer of dimers in the crystal structure, the active site is not near the dimer interface 
(Prochnow, Bransteitter et al.).  Finally, it is important to note that although it is likely 
that AID can form a dimer, there is no direct evidence for dimerization in vitro or in vivo, 
only inference from homology models and co-immunoprecipitation of cell extracts (Xie, 
Sowden et al. 2004; Wang, Shinkura et al. 2006). 
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APOBEC2 & APOBEC3G Oligomeric States 
The clear variation in oligomeric states for the three AID/APOBEC family 
members investigated here suggests that their diverse functionality is mediated, in part, 
by the oligomeric state of the protein.  For example, it has been shown that APOBEC3G, 
exists as either a “high molecular weight species” (~700 kDa) or a “low molecular weight 
species” (~46-100 kDa) in CD4+ T cells (Chiu, Soros et al. 2005).  In unactivated CD4+ 
T cells, which are resistant to HIV infection, APOBEC3G is present in its enzymatically 
active, low molecular weight form; activated CD4+ T cells, which are susceptible to HIV 
infection, have APOBEC3G in the enzymatically inactive high molecular weight form 
(Chiu, Soros et al. 2005).  Since it is possible to convert the high molecular weight form 
of APOBEC3G to the low molecular weight form of APOBEC3G by treatment with 
RNase (Chiu, Soros et al. 2005), it follows that the oligomeric state of APOBEC3G, and 
likely any of the AID/APOBEC family members is regulated by the presence of 
oligonucleotide. 
Our AFM studies of APOBEC2 reveal that at lower concentrations of protein (at 
least lower than the concentration required for crystallization), the protein exists as a 
dimer.  Based on the crystal structure, this suggests that the dimer-dimer interface that 
forms the tetramer is weak (Figure 3.1B).  Since APOBEC2 and AID have 44.6% 
sequence homology, one might expect that they would have similar oligomerization 
states.  Since they don’t, it is possible that the sequence homology is between residues 
buried at the core of the protein.  This idea is supported by the fact that both proteins had 
different affinities for the mica surface (it was difficult to go over 20 nM AID protein 
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because it would coat the surface of the mica while it was possible to get up to 120 nM 
APOBEC2).  
APOBEC3G is seen as a multimer of dimers; forming tetrameric, hexameric and 
even octameric species in solution and in the presence of equimolar ssDNA substrate.   
Since APOBEC3G is known to interact with viral proteins, it seems likely that one of 
these observed oligomeric states is preferential partner for cellular or viral proteins.  
Perhaps, suggested by the work done with activated and unactivated CD4+ T cells (Chiu, 
Soros et al. 2005), the formation of each oligomeric state is partially mediated by the 
interaction of APOBEC3G with either cellular or viral factors. 
Future Directions 
Since phosphorylation of AID seems to play a role in controlling the deamination 
activity of AID (Basu, Chaudhuri et al. 2005), it would be interesting to image the 
phosphorylated protein to see if the phosphorylation makes a difference in 
oligomerization state of AID in the presence and absence of ssDNA substrate.  It would 
also be interesting to have a “bubble” substrate more amenable to AFM imaging (ie: long 
enough to be seen on its own by AFM; >400 nm) to look at the binding / localization of 
AID on the ssDNA region of the substrate.  
Despite the lack of evidence of functionality, it would be interesting to investigate 
the oligomeric state of APOBEC2 in the presence of varying substrates, including 
ssDNA, RNA and free cytidine, to see if any of these possible substrates change the 
oligomerization state.  Perhaps by simply going on a “fishing expedition” it may be 
possible to determine if any of these possible substrates have an effect on the 
 
 
105 
dimerization state of APOBEC2.  However, lack of any results would not rule out 
binding of these substrates to APOBEC2, so these studies should be carried out in 
conjunction with other biochemical techniques.  
 Since APOBEC3G seems to have a preference for forming multimers of dimers, it 
would be interesting to make DNA where there is a double-stranded section that 
separates the two binding sites (-CCC-).  This DNA substrate would allow us to see if 
DNA is being wrapped around protein to form the multimeric states – if  the DNA is 
wrapping around the APOBEC3G, the decrease in DNA flexibility caused by the dsDNA 
region would likely discourage the wrapping of the DNA.  Instead, there would likely be 
two proteins sitting next to each other if both binding sites are bound (kind of a dumbbell 
shaped molecule). 
Materials and Methods 
AID, APOBEC2 & APOBEC3G 
 Purified human AID was purchased from Enzymax (University of Kentucky).  
The proteins APOBEC2 (residues 41-224) and APOBEC3G were provided by Myron 
Goodman (USC).   
DNA substrates 
AID 
 The oligonucleotides used in the deamination assays and the predicted structures 
of the double-stranded oligonucleotides are depicted in Figure 3.2.  The “L-oligo” was 
designed based on the primer used by Yu and colleagues (Yu, Huang et al.), while the 
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single-stranded DNA oligonucleotide (AID1 primer) was based on the CDR2 sequence of 
the human Ig heavy chain VH3-30-3.  Oligonucleotides (100 µM) were 5’-end labeled 
with γ-32P ATP (3000 Ci/mmol, Amersham Biosciences) using Optikinase (United States 
Biochemical Corp.) according to the manufacturer’s instructions. The reaction was 
terminated by the addition of 20 mM EDTA, and the enzyme was heat denatured by 
incubation for 10 minutes at 65°C. After labeling, the free nucleotides were removed by 
gel filtration chromatography (Micro Bio-spin-6, Bio-Rad). For the generation of double-
stranded substrates,  labeled oligonucleotide was annealed with the complimentary strand 
((AID1+AID2 = double strand), (AID1+AID8 = Bubble), and (AID1+AID9 = Loop) see 
Fig. 3.2) using 1.2 molar excess of cold oligonucleotides in the presence of 100 mM KCl, 
heated at 65°C for 5 minutes and slowly cooled to room temperature. The duplexes were 
analyzed on a native 10% polyacrylamide gel. 
APOBEC3G 
DNA substrate used with APOBEC3G (sequence: 5’-GTA TAT ATG TTG AGA 
CCC GTA GTA ATG AGA GAT TGA TTA GAT TAG TTT AAT GTG ATA TAT 
GTG TAT GAA AGA TAT AAG ACC CAG AGA GTA AAG TTG TTA AAT TTG 
TGT AGA TAT GTT (dT-Biotin)A-3’) was provided by Myron Goodman (USC). 
Atomic Force Microscopy 
All AFM images were captured in air using either a Nanoscope III or IIIa (Digital 
Instruments, Santa Barbara, CA) microscope in tapping mode.  Pointprobe Plus tapping 
mode silicon probes (Molecular Imaging, Tempe, AZ) with resonance frequencies of 
approximately 170 kHz were used for imaging.  Images were collected at a speed of 2-3 
 
 
107 
Hz with an image size of 1 µm x 1 µm at 512 x 512 pixel resolution.  Each experiment 
was repeated at least twice.  Volume analysis was done as previously described (Ratcliff 
and Erie 2001; Yang, Wang et al. 2003).  The program Kaleidagraph (Synergy Software, 
Reading PA) was used to generate statistical plots. 
AID 
H100-OAc imaging buffer (20 mM HEPES, pH 7.3; 10 mM MgOAc; 100mM 
NaOAc) was heated to 65°C and allowed to cool slowly.  AID protein was diluted to final 
concentrations of 5, 10, or 20 nM in H100-OAc imaging buffer. For depositions in the 
presence of DNA, AID was incubated with various concentrations of DNA 
oligonucleotides (5 nM-50 nM) for 30 minutes at room temperature prior to deposition.  
After incubation, 10 µl of the AID sample (either in the presence or absence of DNA) 
was deposited onto freshly cleaved mica (Spruce Pine Mica Company, Spruce Pine, NC).  
The sample was rinsed immediately with nanopure water, excess water was wicked from 
the surface using filter paper, and the surface was then dried using a stream of nitrogen.   
APOBEC2 
A3G imaging buffer (50 mM HEPES, pH 7.3; 5 mM MgCl2) was heated to 65ºC 
and allowed to cool slowly.  APOBEC2 was then diluted to 40, 80 or 120 nM in A3G 
imaging buffer and 1 mM DTT was added to the solution.  Ten microliters of the protein 
sample was then deposited onto freshly cleaved mica (Spruce Pine Mica Company, 
Spruce Pine, NC).  The sample was rinsed immediately with nanopure water, excess 
water was wicked from the surface using filter paper, and the surface was then dried 
using a stream of nitrogen.  
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APOBEC3G 
A3G imaging buffer (50 mM HEPES, pH 7.3; 5 mM MgCl2) was heated to 65°C 
and allowed to cool slowly.  APOBEC3G was then diluted to 20 - 50 nM in A3G imaging 
buffer, and 1 mM DTT was added to the sample.  For depositions in the presence of 
DNA, APOBEC3G was incubated with an equimolar concentration of substrate DNA for 
5 minutes before deposition.  Ten microliters of the protein sample were then deposited 
onto freshly cleaved mica (Spruce Pine Mica Company, Spruce Pine, NC).  The sample 
was rinsed immediately with nanopure water, excess water was wicked from the surface 
using filter paper, and the surface was then dried using a stream of nitrogen.  
Deamination assays 
 Typically, a reaction mixture (10 µl) containing 2-100 nM radioisotope-labeled 
oligonucleotide substrate, 5nM-2000nM purified human AID protein (Enzymax, 
University of Kentucky), 100ng of RNase A (Qiagen) and 1 unit of uracil DNA 
glycosylase (UDG, Invitrogen) was incubated for 15 min at 37 ºC in a buffer containing: 
25 mM Tris, pH 8.0, 50 mM NaCl, and 5 mM EDTA (see scheme in Fig. 3.3a).  
To examine deamination at limiting and excess AID protein concentrations, 
deamination reactions were carried out at final AID protein concentrations ranging from 
5 nM to 2 µM and oligo concentrations ranging from 2 nM to 100 nM.  For a subset of 
samples, RNase A  (400 ng) (Qiagen) was pre-incubated with AID for 30 minutes prior to 
addition of the oligo. The reaction was stopped by adding 1 ml of 2 M NaOH and heated 
for 5 min at 95º C. Ten mL of formamide was added and samples were heated at 95º C for 
5 min and loaded on 10% denaturing polyacrylamide gels containing 7 M urea. Gels were 
run in 1X Tris borate-EDTA (TBE) buffer under constant voltage at ambient temperature.  
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Gels were dried and visualized by autoradiography using the phosphor-imager Typhoon 
9400 (Amersham Biosciences) and the bands quantified by ImageQuant software 
(Molecular Dynamics). Deamination rates were determined by fitting the percentage of 
deamination with time to first order exponentials. All deamination reactions were 
repeated at least two times.  
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 CHAPTER 4 
INTERACTIONS OF SALT, ATP, AND/OR DNA WITH yMUTLα 
Introduction 
 
The MMR system is best understood in E. coli, where it is carried out by the 
mismatch repair proteins MutS, MutL and MutH, in addition to a helicase, several 
exonucleases, and the rest of the replication machinery (for review, see (Au, Welsh et al. 
1992; Modrich and Lahue 1996).  Both MutS and MutL, which are homodimeric in E. 
coli, have multiple eukaryotic homologs that function in MMR, as well as other cellular 
processes, as heterodimers.   
In eukaryotes, MMR is believed to be carried out by an array of proteins, 
including the MutS homolog MutSα (Msh2-Msh6), the MutL homolog MutLα (Mlh1-
Pms2 (Pms1 in yeast), PCNA, ExoI, RPA, RFC and DNA Polymerase δ (Constantin, 
Dzantiev et al. 2005; Zhang, Yuan et al. 2005).  The hydrolysis of ATP by both MutSα 
and MutLα is absolutely required for MMR (Iaccarino, Marra et al. 1998; Dufner, Marra 
et al. 2000; Tran and Liskay 2000; Drotschmann, Yang et al. 2002; Hall, Shcherbakova et 
al. 2002; Raschle, Dufner et al. 2002; Tomer, Buermeyer et al. 2002; Kijas, Studamire et 
al. 2003; Lamers, Winterwerp et al. 2003).
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Much work has been done to study the ATPase activity of MutSα (Iaccarino, 
Marra et al. 1998; Dufner, Marra et al. 2000; Drotschmann, Yang et al. 2001; 
Drotschmann, Yang et al. 2002; Lamers, Winterwerp et al. 2003; Lamers, Georgijevic et 
al. 2004), and while there have been ATPase studies done on full length E. coli MutL, the 
only work on MutLα has been on isolated N-terminal domains (Ban and Yang 1998; 
Spampinato and Modrich 2000; Guarne, Junop et al. 2001; Hall, Shcherbakova et al. 
2002).  Interestingly, an N-terminal fragment of E. coli MutL, despite having ADP or  the 
non-hydrolyzable ATP analog AMPPNP bound in the crystal structure (ref), is not able to 
hydrolyze ATP.  In contrast, the N-terminal fragments of MutLα proteins are competent 
for ATP hydrolysis.  A comparison of ATP hydrolysis rates of full-length E. coli MutL 
(with and without an attached His-tag) and for N-terminal fragments MutLα can be found 
in Table 4.1 (Ban and Yang 1998; Spampinato and Modrich 2000; Guarne, Junop et al. 
2001; Hall, Shcherbakova et al. 2002). 
 
 
 
 
117 
Protein Km kcat reference 
His-MutL37°C 90 mM 0.4 min-1 Ban and Yang 1998 
MutL37°C 0.41 mM 0.9 min-1 Spampinato and Modrich 2000 
yMlh11-343, 30°C 69 mM 0.023 min-1 Hall, Shcherbakova et al. 2002 
yPms132-396, 30°C 1500 mM 0.15 min-1 Hall, Shcherbakova et al. 2002 
hPms21-365, rt 100 mM 0.2 min-1 Guarne, Junop et al. 2001 
 
Table 4.1: Comparison of ATP hydrolysis rates for full length MutL and N-terminal 
fragments of MutLα 
Reaction temperatures are listed.  For the N-terminal fragments, the residue numbers 
comprising the fragments are listed. 
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In addition to the information on the ATP binding pocket, the crystal structures of 
an N-terminal fragment of E. coli MutL reveal a putative binding site for single stranded 
DNA (ssDNA) (Ban, Junop, et al. 1999).  The proposed binding site is lined with 
positively charged amino acid residues and is formed by the dimerization of MutL.  
However, the groove is too narrow to account for the binding of dsDNA to MutL 
homologues, which has been demonstrated by other researchers (Hall, Wang et al. 2001; 
Hall, Shcherbakova et al. 2003).  
yMutLα does indeed bind to DNA (Hall, Wang et al. 2001) and has preference 
for long dsDNA over long ssDNA (Hall, Wang et al. 2001).   Binding of yMutLα to the 
DNA occurs mostly in long tracts along either one or two strands of dsDNA (Hall, Wang 
et al. 2001), which suggests that binding to dsDNA is cooperative.  Each N-terminal 
domain of the proteins that make up MutLα is able to bind to DNA in the absence of the 
other protein (Hall, Shcherbakova et al. 2003), suggesting that MutLα has two DNA 
binding sites.   
Since yMutLα binding to DNA is sensitive to concentration of salt, it is believed 
that binding is a result of ionic interactions between regions of positive charge in 
yMutLα and the negative backbone of DNA (Hall, Wang et al. 2001; Hall, Shcherbakova 
et al. 2003).  Indeed, mutations made to arginine residues in N-terminal fragments of 
Mlh1 and Pms1, as well as full length Mlh1 (in complex with wild-type Pms1) decreased 
the binding of the proteins to DNA (Hall, Shcherbakova et al. 2003). 
Despite evidence pointing to two DNA binding sites in eukaryotic MutL proteins 
and the recently discovered endonucleolytic activity of MutLα, DNA binding has yet to 
be incorporated into any sort of MMR mechanism.  Preferential binding of yMutLα to 
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long (>500 bp) dsDNA indicates positive cooperativity (Hall, Wang et al. 2001).  The salt 
dependence of yMutLα binding to DNA suggests that DNA binding by yMutLα is 
primarily a result of ionic contacts between the protein and the DNA phosphate backbone 
(Hall, Wang et al. 2001; Hall, Shcherbakova et al. 2003).  However, the mechanism of 
the formation of yMutLα protein tracts along DNA is unknown, and the relation of the 
protein tracts to the function of MutLα is largely unknown. 
This chapter investigates the effects of Na+ concentration and ATP on the 
formation of protein tracts along homoduplex DNA. Also presented are preliminary data 
on the interaction of yMutLα (at varying ATP concentrations) with nicked plasmid DNA.  
Additionally, since no work has been done to determine the rates of ATP hydrolysis 
using full-length MutLα, and since there are such large conformational changes upon 
adenine nucleotide binding (Chapter 2), including the probable formation of interactions 
between the N-terminal and C-terminal domains, it seems possible that these 
conformational changes could have an effect on the rate of ATP hydrolysis.  For this 
reason, the ATP hydrolysis properties of full-length MutLα are also investigated, and 
presented here in this chapter.  From all these data, predictions of the role of the binding 
of yMutLα to DNA in MMR and other cellular processes can be made. 
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Results 
Effect of Na+ on yMutLα  protein tracts 
yMutLα preferentially forms protein tracts along one strand of  dsDNA 
Previous AFM experiments showed that at low salt (25 mM Na+) yMutLα bound 
to dsDNA in a cooperative manner, forming tracts primarily along two strands of dsDNA 
(2-ds tract, see Figure 4.1 for schematic of possible ways that yMutLα can bind to 
dsDNA) (Hall, Wang et al. 2001).  Reanalysis of these data, as well as analysis of 
additional data collected under similar conditions, revealed that the DNA actually has 
more protein tracts along 1 strand of dsDNA (1-ds tract; Figure 4.1 and 4.2).  These 1-ds 
tracts were likely missed because they tend to coat most of the DNA.   
The 1-ds tracts were discovered when comparing the height of DNA that was 
thought to not have protein on it with the height of DNA alone (deposited in the absence 
of protein).  The DNA containing 1-ds tracts had an average height of 0.94 ± 0.09 nm, 
while the DNA alone had an average height of 0.41 nm.  Since this height difference was 
observed in scans from multiple days and depositions, the only logical explanation for 
this difference in height is that yMutLα is binding to the exposed DNA and forming 1-ds 
tracts.            
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Figure 4.1:  Cartoon of the four possible binding modes of yMutLα on dsDNA.   
DNA is indicated by black line, yMutLα is representated as green oval.  “1-ds binding” 
represents one yMutLα binding to one strand of dsDNA.  “2-ds binding” represents one 
yMutLα binding to two strands of dsDNA.  “1-ds tract” represents multiple yMutLα 
proteins binding and forming a protein tract along 1 strand of dsDNA.  “2-ds tract” 
represents multiple yMutLα proteins binding and forming a protein tract along 2 strands 
of dsDNA.
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Figure 4.2: 3-D AFM image illustrating 1-ds tract formation.   
Pink arrow points to DNA with yMutLα bound (average height of protein-bound DNA is 
0.9 ± 0.1 nm); lime arrow points to DNA without yMutLα bound (average height of 
unbound DNA is 0.4 ± 0.1 nm)
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Increasing Na+ concentration does not affect yMutLα protein tracts along DNA 
 Filter binding studies of yMutLα to DNA show that at 25 mM Na+, 
approximately 70% of DNA is bound by yMutLα.  In these studies, at 100 mM Na+, the 
percent of bound DNA has dropped to 50%, and at 125 mM Na+, ~20% of DNA is bound 
by yMutLα (Hall, Wang et al. 2001). Since electrostatic interactions are believed to be 
involved with yMutLα binding to DNA, AFM imaging was conducted at 100 and 125 
mM Na+ in addition to the imaging done at 25 mM Na+ to see if an increase in Na+ would 
effect the formation of yMutLα protein tracts. 
 To reach this end, the potential protein tracts were verified by visual inspection 
and measurement of height before measuring the length of the tract.  A height greater 
than 0.4 ± 0.1 nm (the average height of DNA alone) along one strand of DNA, coupled 
with the appearance of protein indicated a 1-ds tract; a height greater than 0.8 ± 0.1 nm 
(the average height of two overlapping strands of DNA alone) along two strands of DNA 
coupled with the appearance of protein indicated a 2-ds tract.   
At 25 mM Na+, 78 % of the protein tracts are along 1 strand of dsDNA, and 22% 
of the protein tracts are along 2 strands of DNA (Figure 4.3A). Despite the fact that there 
are more 1-ds tracts than 2-ds tracts, both types of protein tracts have similar distributions 
of length (Figure 4.3B), with an average tract length of 58 nm for 1-ds DNA tracts and 49 
nm for 2-ds tracts.  
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Figure 4.3: yMutLα and DNA in the presence of 25 mM Na+.   
(A) AFM images of yMutLα and DNA at 25 mM Na+.  Images are 1 x 1 µM; scale bar 
represents 500 nm.  (B) distribution of 1-ds (n = 312 tracts) and 2-ds (n = 87) tract 
lengths.  Lengths are plotted as percent of total tracts measured.   
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It should be noted that these data are potentially biased since only protein-DNA 
complexes that were entirely in the AFM image were measured.  There were many 
complexes containing yMutLα and multiple-DNAs that were not measured for this 
reason, and it is possible that the numbers obtained are potentially biased towards 1-ds 
tracts, since 2-ds tracts are often formed by interactions between strands of DNA from 
two different DNA molecules.   
Surprisingly, the AFM data on yMutLα tract formation along DNA at 100 mM 
Na+ and 125 mM Na+ does not appear to reflect a decrease in protein tract formation as 
Na+ concentration increases (Figures 4.4A and 4.5A).  Perhaps these differences may be 
attributed to a difference in buffer (filter binding studies were conducted using Tris 
buffer; AFM studies presented here are done using HEPES buffer).   
At 100 mM Na+, like at 25 mM Na+, 78% of protein tracts are 1-ds tracts and 22% 
of protein tracts are 2-ds tracts (Figure 4.4B).  While the average tract length is 
approximately the same for 2-ds tracts (59 nm) the average length has shifted to 84 nm 
for the 1-ds tracts.  This increase in the length of 1-ds tracts suggests that 100 mM Na+ 
helps to facilitate the formation of 1-ds tracts.   
At 125 mM Na, 80% of protein tracts are 1-ds tracts and 20% of protein tracts are 
2-ds tracts.  Despite this slight increase in 1-ds tracts (and slight decrease in 2-ds tracts), 
the length distributions (Figure 4.5B) are similar to those observed at 100 mM Na+.  The 
average tract length for 2-ds tracts is 55 nm, and the average tract length for 1-ds tracts is 
slightly shorter than the tract length at 100 mM Na+ at 71 nm.  
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Figure 4.4: yMutLα and DNA in the presence of 100 mM Na+.   
(A) AFM images of yMutLα and DNA at 100 mM Na+.  Images are 1 x 1 µM; scale bar 
represents 500 nm.  (B) distribution of 1-ds (n = 341) and 2-ds (n = 94) tract lengths.  
Lengths are plotted as percent of total tracts measured. 
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Figure 4.5: yMutLα and DNA in the presence of 125 mM Na+.   
(A) AFM images of yMutLα and DNA at 125 mM Na+.  Images are 1 x 1 µm; scale bar 
represents 500 nm.  (B) distribution of 1-ds (n = 291) and 2-ds (n = 71) tract lengths.  
Lengths are plotted as percent of total tracts measured. 
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Effect of ATP on yMutLα  binding to DNA at 25 mM Na+ 
 To date, there have been no published studies of yMutLα binding to DNA in the 
presence of ATP.  Since ATP is ubiquitous in the cell, and has been shown to induce 
conformational changes in yMutLα (Chapter 2), it seems possible that DNA binding by 
yMutLα could be affected by the presence of ATP.  To test this hypothesis, yMutLα and 
DNA were imaged by AFM in the absence and presence of 0.1 and 5 mM ATP, and the 
four possible binding modes (Figure 4.1) were tallied.   
With no added adenine nucleotide present, all DNA seen in AFM images has 
protein bound to it (Figure 4.6).  There are no observed single proteins bound to either 
one strand (1-ds binding) or two strands (2-ds binding) of DNA (Table 4.2). In the 
presence of 0.1 mM ATP, the binding of yMutLα to DNA decreases (Figure 4.7), and 
86% of the DNA observed in the images has protein bound to it.  Of the DNA that has 
protein bound to it, there is a decrease in the number of tracts, with tracts making up only 
55% of all binding events.  There is also a decrease in the frequency of 1-ds tracts going 
from 78% of the total protein tracts (in the absence of added ATP) to 1% of the total 
protein tracts (Table 4.2).  There are also single binding events in the presence of 0.1 mM 
ATP, with yMutLα binding to either one strand (1-ds binding) or two strands (2-ds 
binding) of DNA.  Of those single binding events, 68% are 1-ds binding events, and 32% 
are 2-ds binding events. 
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Figure 4.6:  AFM images of yMutLα & DNA in the absence of added adenine nucleotide.   
Scans are 1 x 1 µm; scale bar = 500 nm.
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yMutLα + 
DNA + 
Percentage 
of DNAs 
with 
protein 
bound 
% of 
tracts that 
are 1-ds 
tracts 
% of 
tracts that 
are 2-ds 
tracts 
% tracts / 
total 
binding 
events 
% of 
binding 
events that 
are 1-ds 
binding 
% of 
binding 
events that 
are 2-ds 
binding 
0 mM 
ATP 
100% 78 ± 4% 22 ± 4% 100% not 
observed 
not 
observed 
0.1 mM 
ATP 
86 ± 8% 1 ± 6% 99 ± 6% 55 ± 2% 68 ± 6% 32 ± 6% 
5 mM 
ATP 
65 ± 1% 4 ± 1% 96 ± 1% 43 ± 2% 34 ± 8% 66 ± 8% 
 
Table 4.2:  Statistics for yMutLα binding to DNA in the absence and presence of ATP 
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Figure 4.7:  AFM images of yMutLα & DNA in the presence of 0.1 mM ATP.   
Scans are 1 x 1 µm; scale bar = 500 nm. 
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In the presence of 5 mM ATP, binding of yMutLα to DNA decreases further 
(Figure 4.8), with only 65% of DNA having protein bound.  Protein tracts (both 1-ds and 
2-ds tracts) comprise only 43% of all yMutLα binding events.  The distribution of the 
protein tracts is similar to the distribution seen with 0.1 mM ATP (Table 4.2), with 4% of 
the total protein tracts being 1-ds tracts and 96% of them being 2-ds tracts.  The single 
binding events, however, “switch”; in the presence of 5 mM ATP, 34% are 1-ds binding 
events, and 66% are 2-ds binding events (Table 4.2). 
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Figure 4.8:  AFM images of yMutLα & DNA in the presence of 5 mM ATP.   
Scans are 1 x 1 µm; scale bar = 500 nm. 
 
 
 
134 
Binding of yMutLα  to nicked DNA in the presence and absence of ATP 
 The endonucleolytic activity in MutLα requires, among other things, the presence 
of a nick in the DNA (Kadyrov, Dzantiev et al. 2006).  To see if yMutLα bound to nicked 
DNA differently it binds to covalently closed circular DNA, nicked DNA was imaged 
with yMutLα in the presence and absence of 5 mM ATP.   
 Preliminary data suggest that yMutLα interacts differently with nicked DNA than 
non-nicked, dsDNA in the presence and absence of ATP (Figure 4.9A and B).  In the 
absence of ATP, the extensive tract formation seen with covalently closed circular DNA 
is not seen.  There are single binding events and protein tracts formed, but these are in 
addition to large protein complexes on the DNA that cause looping out of the DNA 
(Figure 4.9C).  Since this is preliminary data, there are no statistics on how frequently 
these large, looped protein complexes form or if they preferentially form under one set of 
conditions. 
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Figure 4.9 
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Figure 4.9:  yMutLα and nicked DNA in the presence and absence of 5 mM ATP.   
(A) yMutLα + nicked DNA in the absence of added adenine nucleotide (B) yMutLα + 
nicked DNA in the presence of 5mM ATP Scan size for both A and B is 1 x 1 µm; scale 
bar is 500 nm  (C) assortment of looped structures seen in the presence and absence of 
ATP.  Scan size is 250 x 250 nm.
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Full-length yMutLα  hydrolyzes ATP faster than N-terminal fragments 
 Even though yMutLα is an ATPase, there have been no published studies of ATP 
hydrolysis using full length protein.  Analysis of the formation of ADP in an ATPase 
assay, spotted on TLC plates, such as that in Figure 4.10 shows that at an ATP 
concentration of 100 µM, ATP is hydrolyzed by yMutLα at a rate of ~2.4 min-1 (Figure 
4.11, Table 4.3).  This rate, based on preliminary data, is 2-6 times larger than what has 
been previously reported for full-length E. coli MutL or the N-terminal fragment of any 
MutL homolog.  Unfortunately, because yMutLα often became catalytically inactive 
before the end of the time course, these rates were only reproducible twice over the full 
60-minutes of the reaction (experiment was repeated 6 times) (Figure 4.11, solid lines are 
linear fits to full 60 minutes.  Looking at the first ten minutes of the reaction (Figure 4.11, 
dashed lines are linear fits to first 10 minutes), however you can see that the protein is 
still functional and actively hydrolyzing ATP, and the rate of ATP hydrolysis is slightly 
faster (Table 4.3, in parentheses). 
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Figure 4.10:  TLC plate monitoring ATP hydrolysis by yMutLα.   
Radiolabelled α-32P-ADP and α-32P-ATP spots are marked. 
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Figure 4.11: Appearance of ADP (as percent of total hot in the reaction) versus time for 
all ATPase reactions done with 100 µM ATP.  
Linear fits are shown for the full 60 minutes of the reaction (solid lines) and for the first 
10 minutes of the reaction (dashed lines).
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Experiment Average Rate of ATP hydrolysis (min-1) 
     Full 60 min reaction (first ten minutes) 
yMutLα + 10µM ATP  0.17 (0.46) 
yMutLα + 50 µM ATP 0.95 (0.91) 
yMutLα + 100 µM ATP 2.4 (2.9 ± 0.89) 
 
Table 4.3: Calculated ATP hydrolysis rates for different concentrations of ATP.   
Data are from the reactions that appeared to go to completion.  Numbers in parentheses 
represent the average rate calculated when using only the first 10 minutes of data.  
Standard deviations are only reported for those values that result from 3 or more rates. 
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At 50 µM ATP, the rate of ATP hydrolysis decreases to 0.93 min -1 (Figure 4.12, 
Table 4.3).  Much like the experiments done at 100 µM ATP, yMutLα frequently became 
catalytically inactive ~10-15 minutes into the 60 minute time course.  Fitting the first 10 
minutes of all data to a line gives an ATP hydrolysis rate of 0.91 min-1 (Table 4.3, in 
parentheses).  At 10 µM ATP, the average rate of ATP hydrolysis decreases further to  
0.17 min-1 (Figure 4.12, Table 4.3).  Interestingly, the first 10 minutes of the 10 µM ATP 
reaction has a hydrolysis rate of 0.46 min-1 (Table 4.3), suggesting that both of the 
reactions done at 10 µM ATP contained yMutLα that became catalytically inactive over 
the course of the experiment.
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Figure 4.12: Appearance of ADP (as percent of total hot in the reaction) versus time for 
all ATPase reactions done with 50 µM ATP.   
Linear fits are shown for the full 60 minutes of the reaction (solid line) and for the first 10 
minutes of the reaction (dashed lines). 
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Figure 4.13: Plot of the appearance of ADP (as percent of total hot in the reaction) 
versus time for all ATPase reactions done with 10 µM ATP.   
Linear fits are shown for the full 60 minutes of the reaction (solid lines) and for the first 
10 minutes of the reaction (dashed lines).
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Nicked DNA may increase the rate of ATP hydrolysis of yMutLα  
 Given that the ATPase activity of MutLα is required for the endonuclease activity 
of the protein, and that yMutLα will bind to nicked DNA, forming looped structures, it 
seemed plausible that the presence of nicked DNA might affect the rate of ATP 
hydrolysis.  To investigate this, the ATPase assays of yMutLα at 100 µM ATP were 
repeated in the presence and absence of 6 nM nicked pUC18 (the same concentration 
used in AFM studies).  While the –DNA reaction (Figure 4.14, blue markers) was 
reproduced twice, the + DNA reaction (Figure 4.14, red markers) only worked once 
without the protein becoming catalytically inactive.   Looking at the first 10 minutes of 
the reactions (both in the presence and absence of DNA), however, shows that nicked 
DNA may not effect the ATPase activity of MutLα.  Calculated rates of ATP hydrolysis 
(using the data from the 1st ten minutes minutes) are 3.3 min-1 in the absence of nicked 
DNA and 3.0 min-1 in the presence of nicked DNA.  
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Figure 4.14: Plot of the appearance of ADP (as percent of total hot in the reaction) 
versus time for all ATPase reactions done with 100 µM ATP ± nicked DNA.   
Blue squares represent experiments done in the absence of nicked DNA, and red circles 
indicate experiments done in the presence of nicked DNA. Linear fits for the full 60 
minutes are shown for three of the four experiments (solid lines).Linear fits to the first 10 
minutes are shown as dashed lines. 
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Discussion 
yMutLα  protein tract formation isn’t sensitive to Na+ 
 Previous filter binding studies showed that increasing salt concentration lead to a 
decrease in the binding of yMutLα to DNA (Hall, Wang et al. 2001).  The AFM results 
presented here show that increasing Na+ concentration does not lead to an apparent 
decrease in yMutLα binding to DNA (as seen by AFM).  These AFM results suggest that 
perhaps the Na+ ion either does not affect binding to DNA as much as expected, or 
perhaps another factor contributed to the filter binding results.  The buffer used in the 
filter binding studies contained Tris, pH 8.0, NaOAc, DTT, and MgCl.  The buffer used 
in the AFM studies contained HEPES, pH 7.3, NaOAc and MgOAc.  Perhaps the buffer 
used, the pH of the buffer used or the counter ion to the Mg may have a synergistic effect 
on the process of DNA binding; working together to enhance or prevent yMutLα from 
binding to DNA at higher salt. 
yMutLα  protein binding is affected by the ATP concentration 
 The experiments conducted in the presence of ATP, taken in conjunction with the 
yMutLα conformational changes observed in the absence of DNA, show that conditions 
that modulate the yMutLα conformation (Chapter 2) also affect its preferred mode of 
binding to DNA (Figure 4.15).  In the absence of added adenine nucleotide, yMutLα 
exists in an extended, v-shaped conformation.  This fact, in conjunction with the AFM 
images of yMutLα in the presence of DNA (with no added adenine nucleotide), suggests 
that the extended conformation of yMutLα will form both 1-ds and 2-ds tracts along 
DNA. 
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Figure 4.15:  Relationship between DNA binding and proposed ATPase cycle for MutLα 
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In light of the fact that the DNA binding domains of yMutLα are in the N-termini, this 
makes sense; since the N-termini are likely extended away from the dimerization domain 
and each other each DNA binding domain is free to interact with sections of DNA that 
are either close (eventually forming 1-ds tracts) or far away (eventually forming 2-ds 
tracts).   
 At 0.1 mM ATP, overall yMutLα binding to DNA has decreased slightly (14%), 
and 1-ds tracts have all but disappeared (Figure 4.15).  In the absence of DNA, at this 
ATP concentration the extended state of yMutLα is still dominant, but an increase in the 
one-armed state of yMutLα is seen (Chapter 2).  It is incredibly interesting that 2-ds 
tracts are still formed; their presence suggests that ATP, while decreasing the total 
number of protein tracts formed (Table 4.2), increases the formation of 2-ds tracts (at 
least when compared to 1-ds tracts).  Also interesting is the observation that of the 
yMutLα single binding events observed, ~2/3 of them are to 1 strand of DNA (1-ds 
binding); it suggests that the one-armed conformation of yMutLα prefers to bind to bind 
to only one strand of DNA, perhaps because one of the N-terminal domains is already 
making contacts with the linker arm or the dimerized C-terminal domains it is 
unavailable for binding to DNA. 
 At 5 mM ATP, yMutLα binding to DNA has decreased even more than at 0.1 
mM ATP, with only 65% of DNA having protein bound (Figure 4.15).  The protein tracts 
now make up only 43% of yMutLα binding to DNA, however the ratio of 1-ds tract to 2-
ds tract is still roughly the same (Table 4.2).  Of the binding events (one yMutLα bound 
to one or two strands of dsDNA) observed, ~2/3 of them are now 2-ds binding events.  
These data suggest that ATP decreases yMutLα 1-ds tract formation dramatically and 
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increases single binding events.  In the absence of DNA, over 70% of yMutLα molecules 
are in the condensed state.  Since both N-termini are believed to be associated with the 
dimerized C-termini in this state, it seems reasonable to think that the DNA binding 
domains are exposed to solvent in this conformation. 
It could be inferred from these data and from the ATPase cycle proposed in 
Chapter 2 that the one-armed state of yMutLα binds preferentially to one strand of DNA, 
while the condensed state of yMutLα binds preferentially to 2 strands of DNA.  These 
shifts in yMutLα binding to DNA at different ATP concentrations also suggest that DNA 
binding may be modulated by the conformational changes of yMutLα, which may play a 
role not only in MMR, but also in its other cellular processes, such as meiotic crossing 
over. 
Hydrolysis of ATP by full-length yMutLα  
 The preliminary data presented in this chapter on the hydrolysis of ATP by full-
length MutLα illustrates that the rate of ATP hydrolysis is faster than previously 
reported.  The most likely explanation for this is that the previous data were on N-
terminal fragments, while this data uses the full protein.  Since it has been demonstrated 
that MutLα undergoes dramatic conformational changes upon ATP binding (Chapter 2), 
it seems reasonable that these conformational changes, and new inter-protein contacts 
formed as a result of the conformational changes, are important for facilitating ATP 
hydrolysis by the full-length protein.   
Another possible explanation for the difference between the hydrolysis rates 
previously measured and those presented here could be that the previous experiments 
were conducted catalytically inactive protein, since the calculated rates of ATP 
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hydrolysis, for those experiments done with full length yMutLα that became inactive 
over the course of the experiment were close to (if not lower than) the previously 
reported rates of hydrolysis.   
   Since the rate of ATP hydrolysis appears to be higher than what has been 
previously reported, it suggests that MutLα might cycle through its conformational 
changes faster (Chapter 2).  Proceeding through the ATPase cycle faster may help 
facilitate the timely repair of mismatched bases by the MMR process, although, if certain 
conformational changes are stabilized by binding to other MMR proteins (such as ExoI, 
PCNA or MutSα), perhaps interaction with those proteins with yMutLα would slow the 
rate of ATP hydrolysis.  Likely a complex series of events keeps the “pace” for MMR. 
Future Directions 
 It would be interesting to look at the effect of buffer identity and pH on yMutLα 
tract formation to see if the buffer identity (Tris vs. HEPES) or its pH has an effect on 
protein tract formation.  It would also be beneficial to repeat the filter binding assays of 
yMutLα to DNA in the buffer used for AFM imaging to see if the results are similar and 
as an attempt to explain the differences between AFM data and filter binding results. 
The multi-protein, looped DNA complexes seen when yMutLα is imaged with 
nicked DNA (both in the presence and absence of ATP) suggest that the interactions of 
yMutLα with nicked DNA are extensive.  These preliminary experiments need further 
work to determine the frequency and extent to which these looped complexes of nicked 
DNA and yMuLα form.  Following that work, it would be interesting to investigate what 
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would happen to these looped complexes if other proteins, like ExoI and PCNA were 
added. 
 Another interesting path to take would be to repeat the experiments testing the 
effect of ATP on binding of yMutLα to DNA, only changing the order of addition.  In the 
original experiments, the ATP was always added to the yMutLα before the addition of 
the DNA.  This order of addition potentially gave the preferred conformational state a 
chance to form before the DNA was added.  Repeating the experiment with the reverse 
order of addition (yMutLα plus DNA first, then ATP) would determine if the pre-
formation of yMutLα conformation is required for the changes seen in yMutLα binding 
to DNA. 
The most interesting experiments to do based on the data on yMutLα binding to 
DNA are also the most difficult.  Ideally, one could imagine yMutLα with DNA in the 
presence of the other mismatch repair proteins it interacts with.  However, all of those 
known proteins (MutSα, PCNA and ExoI) also interact with some form of DNA, which 
may make interpretation of the data complicated.    
Based on the preliminary data on the hydrolysis of ATP by yMutLα in this 
chapter, there are many exciting avenues to take with these experiments.  The first would 
be to repeat these preliminary experiments, and add in some higher concentrations of 
ATP in an attempt to get kinetic parameters for the hydrolysis reaction.  In addition, it 
would be interesting to assay the ATPase activity of MutLα in the presence of other 
MMR proteins.  However, given the fact that two of the three proteins that MutLα is 
known to interact with in the MMR pathway also hydrolyze ATP, those proteins would 
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only complicate the assay.  Perhaps a better place to start would be to see if the ATPase 
activity of MutLα is changed in the presence of PCNA. 
 The drugs radicicol and geldanamycin have been shown to inhibit the ATPase 
activity of type II topoisomerases and Hsp90s (Soti, Racz et al. 2002; Immormino, 
Dollins et al. 2004; Chu, Maynard et al. 2006; Corbett and Berger 2006; Gadelle, Graille 
et al. 2006), both members of the GHL ATPase family.  Since MutLα is also a member 
of that ATPase family, it seems reasonable to expect that the drugs would also inhibit the 
ATPase activity of MutLα.  This could be tested by incubating MutLα with either 
radicicol or geldanamycin for a period of time before addition of ATP to start the 
reaction.   
It would also be interesting to look at the ATPase activity of Mlh1 alone, since it 
is possible to purify it.  Thus far, no purification of full-length yPms1 or hPms2 alone has 
been reported.  The ATP hydrolysis experiments using Mlh1 alone could help to 
elucidate the roles of both proteins in the hydrolysis of ATP. 
Materials and Methods 
Chemicals 
 ATP was purchased from Sigma. Radiolabelled ATP (α-32P ATP, 800 Ci/mmol) 
was purchased from MP Biomedicals. 
Protein Expression and Purification 
 yMutLα was purified as previously described (Hall and Kunkel 2001), with the 
exception of HEPES, pH 7.3 being used in the dialysis buffer instead of Tris, pH 7.3.   
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DNA Substrates 
Relaxed pUC18 
Relaxed pUC18 was generated by reacting pUC18 with Topoisomerase II (USB) 
for 1 hours at 30°C.  The reaction was terminated by addition of 7 mM EDTA and 0.77% 
SDS.  To check for DNA relaxation, a portion of each reaction was run on a 1% agarose 
gel in the absence of ethidium bromide, stained in a solution of ethidium bromide (0.5 
µg/mL) for 30 minutes, and destained for 30 minutes in ddH2O.  Reactions that went to 
completion were then purified using a GFX PCR purification kit (Amersham) and stored 
at -20°C until being used in imaging.   
Relaxed pBluescript 
Relaxed pBluescript was a gift from Jode Plank at Duke.   
Nicked pUC18 
 Nicked DNA was generated by digesting pUC18 with the nicking enzyme 
Nt.BstNB I (NEB) for 3 h at 55 °C, followed by enzyme inactivation at 80 °C for 20 min.  
DNA was separated from the inactivated nickase by filtering it through Micropure-EZ 
enzyme filters (Microcon).  To check the state of the nicked DNA, it was imaged by 
AFM in buffer (25 mM HEPES, pH 7.3; 100 mM NaOAc; 10 mM MgOAc).  If the DNA 
appeared relaxed on the surface, then it was assumed that there was at least one nick 
present. 
Atomic Force Microscopy  
AFM images were captured in air using either a Nanoscope III or IIIa (Digital 
Instruments, Santa Barbara, CA) microscope in tapping mode.  Pointprobe Plus tapping 
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mode silicon probes (Agilent Technology, Tempe, AZ) with resonance frequencies of 
approximately 170 kHz were used for imaging.  Images were collected at a speed of 2-3 
Hz with image sizes of 1.5 - 2 µm at 512 x 512 pixel resolution.  
 Images were analyzed using Nanoscope III v5.12r3 software (Veeco, Santa 
Barbara, CA), Image SxM, v 1.69 (Barrett 2006) and NIH ImageJ (Rasband 1997-2006) 
with OpenAFM and Cell Counter plug-ins.  Statistical plots were generated with 
Kaleidagraph (Synergy Software, Reading, PA). 
Salt-Dependence of tract formation 
 To determine the effect of Na+ on yMutLα protein tract formation, yMutLα was 
diluted to a final concentration of 30 nM in one of three imaging buffers in the presence 
of relaxed pUC18.  Each buffer contained 20 mM HEPES, pH 7.3, 5 mM MgOAc and 
then NaOAc at either 25, 100 or 125 mM. A volume of 10 µl of the sample was deposited 
onto freshly cleaved ruby mica (Spruce Pine Mica Company, Spruce Pine, NC).  The 
sample was rinsed immediately with nanopure water; excess water was blotted from the 
surface, and the surface was then dried using a stream of nitrogen. 
Effect of ATP on yMutLα binding to DNA 
 To determine the effect of ATP on the binding of yMutLα to DNA, yMutLα was 
diluted to a final concentration of 30 nM in imaging buffer (20 mM HEPES, pH 7.3, 10 
mM MgOAc, 25mM NaOAc) in the presence of 2 nM relaxed pBluescript DNA.  A 
volume of 10 µl of the sample was deposited onto freshly cleaved ruby mica (Spruce Pine 
Mica Company, Spruce Pine, NC).  The sample was rinsed immediately with nanopure 
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water; excess water was blotted from the surface, and the surface was then dried using a 
stream of nitrogen. 
 For experiments where ATP was present, ATP and yMutLα were mixed and then 
diluted in imaging buffer to a final adenine nucleotide concentration of 0.1 mM or 5 mM 
and protein concentration of 30 nM before the addition of relaxed DNA to a final 
concentration of 2 nM.  The sample was then deposited the same as for MutLα protein 
and DNA alone. 
yMutLα binding to nicked DNA in the absence and presence of ATP 
 To determine the binding of yMutLα to nicked DNA and to see if ATP would 
effect this binding in any way, yMutLα was diluted to a final concentration of 30 nM in 
imaging buffer (20 mM HEPES, pH 7.3, 10 mM MgOAc, 25mM NaOAc) in the presence 
of 6 nM nicked pUC18 DNA.  A volume of 10µL of the sample was deposited onto the 
freshly cleaved ruby mica (Spruce Pine Mica Company, Spruce Pine, NC).  The sample 
was rinsed immediately with nanopure water; excess water was blotted from the surface 
and the surface was then dried using a stream of nitrogen.  
 For experiments where ATP was present, ATP and yMutLα were mixed and then 
diluted in imaging buffer to a final adenine nucleotide concentration of 0.1 mM or 5 mM 
and protein concentration of 30 nM before the addition of relaxed DNA to a final 
concentration of 2 nM.  The sample was then deposited the same as for MutLα protein 
and DNA alone. 
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TLC Plate Preparation 
 Before using the PEI cellulose TLC plates (Selecto Scientific), spot locations 
were marked and the plates were pre-run in ddH2O to remove any residual material from 
the surface.  The plates were then dried flat overnight. 
 
ATPase assays 
Determination of the Rate of ATP Hydrolysis  
yMutLα (200nM) was mixed with reaction buffer (25 mM HEPES, pH 7.3; 100 
mM NaOAc; 10 mM MgOAc) for a final reaction volume of 20 µL.  Labeled ATP (α-32P 
(10, 50 and 100µM final ATP concentration)) was added to initiate the ATPase reaction.  
At 0, 1, 5, 10, 20, 30, 40, 50 and 60 minutes, 1 µL of reaction was removed and added to 
4 µL of formamide to quench the reaction.  Two µL of each quenched time point was 
then spotted on pre-run PEI cellulose TLC plates (Selecto Scientific) and ran in 0.3 M 
KPO4 buffer, pH 7.0.  TLC plates were exposed to phosphor imager screens for 1 hour 
and read on a Storm Phosphorimager (Molecular Dynamics).  Lanes were quantified 
using Image Quant software (Molecular Dymanics) and kinetic analysis was done with 
Kaleidagraph (Synergy, PA).  
Effect of DNA on Rate of ATP Hydrolysis 
yMutLα (200nM) was mixed with reaction buffer (25 mM HEPES, pH 7.3; 100 
mM NaOAc; 10 mM MgOAc) in the presence and absence of 6 nM nicked pUC18, for a 
final reaction volume of 20 µL.  Labeled ATP (α-32P (100 µM)) was added to initiate the 
ATPase reaction.  At 0, 1, 5, 10, 20, 30, 40, 50 and 60 minutes, 1 µL of the reaction was 
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removed and added to 4 µL of formamide to quench the reaction.  Two µL of each 
quenched time point was then spotted on pre-run PEI cellulose TLC plates (Selecto 
Scientific) and ran in 0.3 M KPO4 buffer.  TLC plates were exposed to phosphor imager 
screens for 1 hour and read on a Storm Phosphorimager (Molecular Dynamics).  Lanes 
were quantified using Image Quant software (Molecular Dymanics) and kinetic analysis 
was done with Kaleidagraph (Synergy, PA).  
Calculation of ATP hydrolysis rates 
ATP hydrolysis rates were calculated using the slope of the linear fit of the data of 
the appearance of ADP versus time.  The slope, which reports the appearance of ADP as 
percent/minute, is directly related to the disappearance of ATP, since as ATP disappears, 
it is being converted to ADP.  Multiplying the slope by the concentration of ATP used 
gives a rate in concentration/min, which, when the concentration of yMutLα is taken into 
account, can be converted into number of ATPs hydrolyzed per minute.   
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APPENDIX A 
MATERIALS & METHODS 
 
Buffers for AFM imaging 
 All buffers for AFM imaging (see Table A.1 for recipes) were made from 1 M 
stock solutions of each component (e.g.: 1 M NaOAc, 1 M MgOAc, 1 M HEPES, etc.) 
and diluted to the appropriate volume with nanopure water.  Typically, 10 mL of buffer 
was made at a time, filtered at least twice with 0.02 µm Anotop syringe filters 
(Whatman), aliquoted into 1.5mL eppindorf tubes and stored at 4°C.  Before use in 
imaging, buffers were heated to 65°C for at least 10 minutes and cooled slowly to room 
temperature.  
Mica Substrates 
 Ruby mica (Spruce Pine Mica, Spruce Pine, NC) was affixed to metal discs (Ted 
Pella) using Tempfix adhesive (Ted Pella).  To affix mica, the metal discs were heated 
directly on a hot plate, the heat-sensitive glue was dabbed onto the center of the disc and 
the piece of mica was placed directly on top of the glue.  Pressure was applied to spread 
the glue and the discs were removed from the hot plate with tweezers and allowed to 
cool.  Immediately before sample deposition, the top layer of mica was cleaved off with 
the use of transparent tape. 
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AFM 
AFM experiments were conducted using a Nanoscope III or IIIa AFM (Veeco, 
Santa Barbara, CA) operated in tapping mode in air.  All imaging samples were prepared 
similarly.  The buffer and DNA (if DNA is being used in the experiment) were first 
heated to 65°C and incubated for 10 minutes before being slowly cooled to room 
temperature.  If any protein is being used in the experiment it was added at this point and 
the sample was then diluted with buffer to an appropriate concentration for the 
experiment.  A volume of 10-20 µL was then deposited either directly onto freshly 
cleaved mica or onto a small square of parafilm, after which the mica was lowered to the 
sample drop. The sample on the mica was then rinsed immediately with nanopure water; 
excess water was wicked from the surface using a piece of filter paper. The sample was 
then dried under a gentle stream of nitrogen gas, and placed in the AFM for imaging. 
Pointprobe Plus tapping mode silicon probes (Agilent Technology, Tempe, AZ) 
with resonance frequencies of approximately 170 kHz were used for imaging.  Images 
were collected at a speed of 2-3 Hz with an image size of 1 - 2 µm at 512 x 512 pixel 
resolution. 
Nanoscope III v5.12r3 software was used for image analysis. Volume analysis 
was done as previously described (Ratcliff and Erie 2001; Yang, Wang et al. 2003) using 
Image SXM v1.69 software (Barrett 2006).   Image analysis was done using NIH ImageJ 
v 1.37 (Rasband 1997-2006) with the plugins OpenAFM (to open AFM images in 
ImageJ) and CellCounter (to tally shapes of molecules on the surface).  Statistical plots 
were generated using Kaleidagraph (Synergy Software, Reading, PA). 
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Buffer Name Purpose Components 
HEPES 25-OAc  
(H25-OAc) 
yMutLα protein tract 
formation 
 
yMutLα adenine nucleotide 
induced conformational 
changes 
25 mM HEPES, pH 7.3 
5 mM MgOAc 
25 mM NaOAc 
HEPES 25-OAc-10Mg  
(H25-OAc-10Mg) 
yMutLα adenine nucleotide 
induced conformational 
changes 
 
interactions of yMutLα 
with nicked DNA 
25 mM HEPES, pH 7.3 
10 mM MgOAc 
25 mM NaOAc 
HEPES 100-OAc 
(H100-OAc) 
yMutLα protein tract 
formation 
 
yMutLα adenine nucleotide 
induced conformational 
changes 
 
interactions of yMutLα 
with nicked DNA 
 
AID oligomerization state 
20 mM HEPES, pH 7.3 
10 mM MgOAc 
100 mM NaOAc 
HEPES 125-OAc 
(H125-OAc) 
yMutLα protein tract 
formation 
20 mM HEPES, pH 7.3 
10 mM MgOAc 
125 mM NaOAc 
HEPES 150-OAc 
(H150-OAc) 
yMutLα protein tract 
formation 
20 mM HEPES, pH 7.3 
10 mM MgOAc 
150 mM NaOAc 
EcoRV buffer 
(1-D diff) 
1-dimensional diffusion 
project using EcoRV 
10 mM HEPES, pH 7.3 
50 mM NaCl 
10 mM CaCl2 
APOBEC3G 
(A3G) 
APOBEC3G 
oligomerization state 
 
APOBEC2 oligomerization 
state 
50 mM HEPES, pH 7.3 
5 mM MgCl2 
 
Table A.1: AFM Buffers  
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yMutLα  Protein Purification 
This is a detailed version of a published procedure (Hall and Kunkel 2001), along 
with the adjustments necessary to do the first column in batch, so that the purification of 
yMlh1-Pms1 from yeast can be repeated with minimal assistance.  Recipes for all buffers 
and media can be found in tables A.2, A.3 and A.4. 
Transformation: 
The Saccharomyces cerevisiae strain BJ2168 was transformed with plasmids 
pMH1 (Mlh1 and Trp coding sequences) and pMH8 (Pms1 and Leu coding sequences) 
(both plasmids are from the Kunkel Lab at NIEHS), following standard yeast 
transformation procedure using LiOAc (Ausubel 1987).  Briefly, 5 mL of YPD media 
was inoculated with a single colony of BJ2168 and grown overnight at 30°C.  To this 
growth, 20 mL of YPDA was added, and growth continued at 30°C for another 6 hours.  
An aliquot of 1.5 mL of the culture was removed, pelleted in a microcentrifuge, and the 
supernatant was discarded.  Carrier DNA (200 µg salmon sperm DNA) and ≤ 2.5 µg of 
each transforming DNA were added to the tube containing the pelleted yeast cells.  Fresh 
PEG solution (1.2 mL) was added to the cells and DNA and the whole reaction was 
incubated for 30 minutes at 30°C.  The tube was then placed in a 42°C water bath for 
exactly 15 minutes.  Following heat shock, the cells were spun down and the supernatant 
was discarded.  The cell pellet was resuspended in 200 µL of TE, and 100 µL of the 
transformation as well as 100 mL each of 1:5 and 1:10 dilutions were plated on selective 
plates (SC-trp –leu) and allowed to grow for 3 days at 30°C. 
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Growth & Induction: 
Overnight cultures (usually four) were started from the plate of transformed yeast 
and grown in 10 mL of selective media (SCGE–trp –leu) for 24h with shaking at 30°C.  
From these 10 mL cultures, 4 x 1L cultures were started, and grown in SCGE-trp-leu for 
24h with shaking (225 rpm) at 30°C (resulting in a final culture density of OD595 ~1). The 
cell culture was pelleted at 6000 x g for 5 minutes in four 500 mL centrifuge bottles, and 
the supernatant decanted.  The cell pellet was then resuspended in a minimal amount 
(~45 mL per centrifuge bottle, 180 mL total) of YP-Gal, and to induce the galactose-
regulated production of Mlh1 and Pms1 the resuspended cells (~12 mL per flask) were 
then used to inoculate 16 flasks each containing 1L of YP-Gal.  Cultures were grown 
with shaking (225 rpm)  at 30°C until the OD595 reached between 1.2 -1.3 (16-18 hours). 
Cells were harvested by centrifugation at 6000 x g for 5 minutes in 6 x 500 mL 
centrifuge bottles.  Cell pellets were washed with a minimal amount (~35 mL per bottle) 
of sterile water and consolidated into one centrifuge bottle.  Cells were then spun for 15 
minutes at 6000 x g.  The water was decanted and cell pellet frozen at -80°C until ready 
to proceed with the protein purification.   
Typical cell pellets from 16L of culture were around 100g, and normally lead to 
0.8 mg of purified yMutLα.  Unfortunately, yMutLα responds poorly to centrifugal 
ultrafiltration, so to obtain more concentrated protein, two growths (a total of 32 L of 
culture eluted with the same volume off the final column) are recommended.   
Purification: 
Unless stated, all procedures are done at 4°C.   
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Cell pellet was removed from storage at -80°C and thawed overnight on ice in the 
cold room.   
Six protease inhibitor tablets (Roche, cOmplete EDTA-free) and PMSF (0.5 mM 
final concentration) were added to ~200 mL of chitin column buffer and allowed to stir 
until everything was dissolved.  The thawed cell pellet was resuspended in a minimal 
amount of this ~200 mL of chitin column buffer.  Half of the cell pellet was then left on 
ice while the other half and an equal volume of 0.5 mm glass beads  (Biospec Products) 
were placed in a bead beater equipped with jacket.  The bead beater jacket was packed 
with ice and water and the cells were beat for a total of 8 minutes, in 1-minute increments 
with a 5-minute rest period in between each beating.  The lysed cells were separated from 
the beads using a pipette, and the lysis procedure was repeated using the remaining half 
of the resuspended cells.  Lysed cells and beads were then centrifuged at 6000 x g to 
separate the cell debris from the supernatant.  The pellet was discarded and the 
supernatant was centrifuged in an ultracentrifuge at 12,500 x g for 30 minutes at 4oC.   
While the ultracentrifuge was running, 30 mL of Chitin Beads (NEB) were 
washed 5 times, with 20 mL each time, of Chitin Column buffer.  The beads were spun in 
50 mL polypropylene conical tubes at 2500 x g for 5 minutes to pellet.  After the washes, 
the beads were resuspended in 20 mL of chitin column buffer and divided between six 
new 50 mL conical tubes. 
Following ultracentrifugation the supernatant, containing yMutLα, was removed 
and a 5% Polymin P solution was added gradually (20 µL Polymin P for every 1 mL of 
supernatant) to precipitate DNA and RNA.  The solution was allowed to stir for 30 
minutes, and then centrifuged at 10,000 x g for 10 minutes.  The supernatant was 
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distributed between the 6 tubes containing chitin beads, and the remaining volume was 
filled with chitin column buffer.  The tubes were rotated at 4oC for 1 hour, in order for 
yMutLα to bind to the chitin beads.   
After the hour-long binding period, the beads were washed 4 times with 20 mL of 
chitin column buffer each time and spun at 2500 x g for 5 minutes.  The chitin beads 
were then washed twice with 20 mL each of ATP wash buffer and spun at 2500 rpm for 5 
minutes.  The beads were finally resuspended in minimal ATP wash buffer and poured 
into the column with flow adaptor (BioRad; 1.7 cm ID).  The column was allowed to 
settle before 20 mL of DTT-containing cleavage buffer was loaded onto the chitin 
column at a rate of 1 mL/min and allowed to sit on the column overnight (approximately 
12 hours). 
Free Mlh1 and Pms1 were eluted from the chitin column with 30 mL of buffer A 
+ 100 mM NaCl at a rate of 0.5 mL/min directly onto a 5 mL HiTrap Heparin-Sepharose 
column (GE biosciences) pre-equilibrated with buffer A plus 100 mM NaCl  (Heparin 
column was attached directly to the outlet of chitin column).  The chitin column was then 
disconnected and the heparin column was washed with 15 mL buffer A + 100 mM NaCl 
(rate 0.5 mL/min).  Mlh1 and Pms1 were then eluted into 1 mL fractions by a 50 mL 
linear gradient of NaCl (100-1000 mM) in buffer A.  Mlh1 and Pms1 eluted around ~500 
mM NaCl.  Elution fractions containing Mlh1 and Pms1 were pooled. 
The conductivity of the pooled fractions was measured, and adjusted to a final 
NaCl concentration of 100 mM using equation A.1, where Vpool is the volume of pooled 
fractions in mL, Cpool is the conductivity of pooled fractions in µS, x is the volume of 
buffer A + no salt to add, CA-NS is the conductivity of buffer A + no salt and Cfin is the 
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desired final conductivity.  The sample was then loaded at 0.5 mL/min using a Superloop 
onto a 1 mL DEAE-Sepharose column (GE biosciences) equilibrated with Buffer A + 
100 mM NaCl.     
 
Equation A.1   ((Vpool)(Cpool)) + x(CA-NS)=((x+Vpool)(Cfin)) 
 
The DEAE column was washed with 4 mL of buffer A + 100 mM NaCl at 0.5 mL/min, 
and then Mlh1-Pms1 was eluted with a 10 mL linear gradient of buffer A + NaCl (100 
mM – 1000 mM) at 0.5 mL/min. Mlh1-Pms1 typically eluted at ~ 180 mM NaCl.  
Bradford analysis (Bradford 1976) was performed on fractions in and around the peak 
before those fractions were pooled and dialyzed overnight against 1L dialysis buffer. 
 Following dialysis overnight (~12h), final protein concentration was determined 
via Bradford analysis (Bradford 1976).  The protein was then aliquoted (100 µL aliquots), 
flash frozen in liquid N2 and stored in liquid N2 storage until needed, at which point the 
aliquot was thawed on ice and either used in its entirety or aliquoted into smaller 
volumes, flash frozen in liquid N2 and stored at -80°C. 
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YPD 10 g yeast extract 
20 g BactoPeptone 
900 mL ddH2O 
 
autoclave 20 min (liquid cycle) & let cool 
45 min – add 100 mL sterile 20% glucose 
YPDA 10 g yeast extract 
20 g BactoPeptone 
885 mL ddH2O 
 
autoclave 20 min (liquid cycle) & let cool 
45 min – add 100 mL sterile 20% glucose 
and 15 ml of a 0.2% adenine hemisulfate 
solution 
PEG solution 8 mL of 50% w/v PEG 3500 or 4000  
1 mL of 10x TE buffer, pH 7.5 
1 mL of 10x (1M) LiOAc, pH 7.5 
Table A.2 yMutLα transformation solutions and media 
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Amino Acid Mix (-trp, -leu) 1 g        adenine 
1 g        uracil 
1 g        histidine 
1 g        arginine 
1 g        methionine 
2.52 g   phenylalanine 
3 g        tyrosine 
3 g        lysine 
4 g        isoleucine 
5 g        aspartic acid 
5 g        glutamic acid 
7.24 g   valine 
10 g      threonine 
20 g      serine 
 
mix well and store in dark glass or foil 
covered bottle 
SC-trp-leu plates 6.7 g yeast nitrogen base, w/o AAS 
1.4 g amino acid mix (-trp, -leu) 
20 g agar 
900 mL ddH2O 
 
autoclave 20 min (liquid cycle) & let cool 
45 min – add 100 mL sterile 20% glucose 
before pouring plates 
SCGE-trp-leu media 6.7 g yeast nitrogen base, w/o AAS 
60 mL 50% glycerol 
20 mL 200 proof Ethanol 
1.4 g amino acid mix (-trp, -leu) 
915 mL ddH2O 
 
autoclave 20 min (liquid cycle) & let cool 
45 min then add 5 mL sterile 20% glucose 
YP-Gal 20 g bactopeptone 
10g yeast extract 
950 mL ddH2O 
 
autoclave 20 min (liquid cycle) & let cool 
45 min, then add 50 mL sterile 40% 
galactose 
 
Table A.3: yMutLα media  
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5% Polymin P (Polyethylenimine) solution 
(50 mL) 
 
5.35g Polymin P to ~30 mL ddH2O 
pH to 7.7 with 12 N HCl 
ddH2O to 50 mL 
 
filter sterilize 
Chitin Column Buffer (1L) 25 mM Tris-HCl, pH 8.0   
500 mM NaCl     
10% glycerol     
0.1 mM EDTA   
ddH2O to 1L 
 
filter sterilize 
ATP Wash Buffer (150 mL) 
 
25 mM Tris-HCl, pH 8.0 
200 mM KCl  
10 % glycerol  
3 mM MgCl2  
ddH2O to 150 mL 
 
filter sterilize 
 
**before use:  add ATP to 100 µM final 
concentration** 
Cleavage Buffer (100 mL) 
 
25 mM Tris-HCl, pH 8.0  
100 mM NaCl 
10 % glycerol 
0.1 mM EDTA  
ddH2O to 95 mL 
 
filter sterilize 
 
**before use:  add DTT to 50 mM final 
concentration** 
2x Buffer A (DEAE column) (250 mL) 
 
50 mM Tris-HCl, pH 8.0 
20 % glycerol   
0.2 mM EDTA 
40 mM DTT  
ddH2O to 250 mL 
 
filter sterilize 
 
**keep in cold room once made** 
Buffer A + 100 mM NaCl (250 mL) 
 
125 mL 2x Buffer A 
5 mL 5M NaCl 
ddH2O to 250 mL 
 
filter sterilize 
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Buffer A + 1M NaCl (100 mL) 
 
50 mL 2x buffer A 
20 mL 5M NaCl 
ddH2O to 100 mL 
 
filter sterilize 
1x Buffer A (no salt) (100 mL) 
 
50 mL 2x Buffer A 
ddH2O to 100 mL 
 
filter sterilize 
Dialysis Buffer (1L) 
 
25 mM Tris-HCl, pH 8.0  
10 % glycerol    
0.1 mM EDTA    
100 mM NaCl     
1 mM DTT     
 
ddH2O to 1 L 
Table A.4: yMutLα Protein Purification Solutions 
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